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Abstract
The aim of this project was to study the dynamics of intramammary infection and 
resulting inflammation in Staphylococcus aureus mastitis in cows. Four cows with 
naturally occurring subclinical mastitis in one or more quarters, caused by S. aureus, 
were used in this study.
The strains of S. aureus causing infection in the cows were determined by restriction 
enzyme fragmentation pattern (REFP) analysis. Two cows were infected with one strain 
of S. aureus, designated strain A, and two cows were infected with a different strain of S. 
aureus, designated strain B. The cows were subsequently challenged by the 
intramammary route in a novel cross-over design with large numbers (lOMO9) of either 
the indigenous strain or the non-indigenous strain of S. aureus. Quarters which were 
naturally infected with S. aureus and then challenged by the intramammary route with S. 
aureus remained persistently infected three weeks following challenge in three of the four 
cows, irrespective of the challenge strain. The fourth cow required treatment with 
antibiotics due to an increase in the severity of mastitis. The results of this study showed 
that in one cow, intramammary challenge of a subclinically infected quarter with the 
indigenous strain of S. aureus failed to induce an anamnestic immune response which 
might have instigated clearance of the original infection from the quarter; while in the 
other cow, the indigenous strain was replaced with three distinct isolates. It also showed 
that intramammary challenge of a subclinically infected quarter with the non-indigenous 
strain of S. aureus, in two cows, did not result in permanent replacement of the 
indigenous strain with the recently infused non-indigenous strain. In addition to the 
original strains A and B, eight distinct strains isolated from the four cows, were 
recognised by REFP analysis, indicating that a cow, or even a quarter, may be infected 
simultaneously by more than one strain of S. aureus. This study showed that the 
examination of multiple colonies per milk sample was required in order to identify the 
diversity of S. aureus strains present and to maximise the benefit of bacterial strain 
identification as an epidemiological tool in mastitis investigations. As REFP analysis is a 
time consuming method, a repetitive extragenic palindromic polymerase chain reaction 
(REP-PCR) was developed during this project to facilitate more rapid identification of the 
ten S. aureus strains originally identified by REFP.
To investigate the acute phase response as an indicator of inflammation in mastitis, 
mammary secretions from the four cows with naturally occurring subclinical mastitis 
caused by S. aureus were collected prior to, and following, intramammary challenge with 
S. aureus. Serum amyloid A (SAA) was isolated and purified from the serum of bovine 
clinical cases by ultracentrifugation, gel electrophoresis and electro-elution. Serum 
amyloid A was identified by enzyme linked immunosorbent assay and immunoblotting 
using a polyclonal rabbit anti-human SAA antibody. The purified SAA was used to 
immunise mice in an attempt to produce a monoclonal antibody specifically against 
bovine SAA but this proved to be unsuccessful even when the SAA was bound to a 
carrier protein. Increased levels of haptoglobin were identified in mammary secretions 
from a single quarter of one cow. This quarter had been originally uninfected and then 
challenged by the intramammary route with strain B. In the absence of a polyclonal or 
monoclonal antibody to bovine SAA, sodium dodecyl sulphate polyacrylamide gel 
electrophoresis was used to identify proteins in mammary secretions with a similar 
molecular weight to SAA. A protein of similar molecular weight to SAA was identified in 
the same quarter in which the increased haptoglobin levels were measured.
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Chapter 1
Introduction
1.1 Mastitis
1.1.1 The Disease
Bovine mastitis is a serious welfare and economic problem in the United 
Kingdom. Mastitis is recognised as one of the major diseases adversely affecting 
dairy cow welfare and is the single most common cause of death in adult cows 
(Menzies et al.y 1995). Peracute and acute mastitis are recognised as significant 
causes of poor welfare in dairy cows (Logue and Hillerton, 1996), whereas the 
major impact of subclinical mastitis is in reduction of farm income (Blosser, 1979; 
Rebhun, 1995). Mastitis causes greater financial loss to the dairy industry than 
any other disease (De Graves and Fetrow, 1993), with 70% of this loss 
attributable to reduced milk production caused by cases of subclinical mastitis, 
many of which remain undetected for a considerable time (Sandholm and Mattila, 
1986). Mastitis affects both the quality and quantity of the milk produced (De 
Graves and Fetrow, 1993; Blowey and Edmondson, 1995). The reduction in yield 
of milk is due to irreversibly damaged milk secretory tissue and the compositional 
changes in the milk which occur during a mastitic attack, which adversely affect 
the processing qualities of the milk and its products (Castle, 1985). Within the 
quarter, a low grade infection may steadily destroy the secretory cells, especially
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the ducts, which are then replaced by scar tissue, thus reducing the capacity of the 
quarter to produce milk (Webster, 1993). Compositional changes in the milk vary 
depending on the severity of infection, the causative micro-organism involved, the 
stage of lactation of the cow and the susceptibility of the individual animal 
(Webster, 1993). Mastitic milk is unacceptable to the consumer and some 
mastitis pathogens constitute a public health risk, including some strains of 
Staphylococcus aureus which produce enterotoxins known to cause gastro­
enteritis in humans (Batish et al., 1988; Harvey and Gilmour, 1990; Orden et al.,
1992).
Mastitis, defined as inflammation of the mammary glands, produces clinically 
recognisable signs of heat, pain, swelling and inflammation of the affected 
quarters (Blowey, 1990). The majority of cases of bovine mastitis result from 
colonisation of the mammary gland by pathogenic bacteria (Sandholm and 
Mattila, 1986). Many different bacteria cause mastitis and the diversity of 
bacteria initiating infection is one of the major problems in rational treatment of 
the disease (Webster, 1993). Mastitis can be classified into peracute, acute, 
subacute, chronic and subclinical cases depending on the severity of the attack 
(Radostits et al., 1994). In peracute mastitis, the udder becomes grossly inflamed 
and the resultant mammary secretions are considerably altered. The cow usually 
displays symptoms of severe systemic illness which can be fatal (Webster, 1993). 
Acute mastitis is less severe than peracute, however the udder is still swollen and 
inflamed and the animals temperature may be elevated, although the systemic 
symptoms are less marked than in the peracute form (Black, 1992). Subacute 
mastitis is characterised by mild inflammation, including abnormal milk secretion, 
whereas chronic mastitis is associated with recurrent attacks of inflammation 
(Radostits et al., 1994). The cow with a chronically infected quarter is not only 
less productive, but acts as a continual source of infection to other quarters and 
cows (Webster, 1993). Subclinical mastitis is difficult to detect, with no visible 
abnormality of the milk or udder, and an elevated somatic cell count is taken as 
the usual indicator of infection. Somatic cells include epithelial cells, lymphocytes 
and monocytes but mainly consist of polymorphonuclear leucocytes (PMNL) 
(Lam, 1996). The main factor that determines the somatic cell count (SCC) is the
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infection status (Shepers et al., 1996) but other factors include the number of 
infected quarters, the causative organism, the age of the cow and the stage of 
lactation (Emanuelson and Funke, 1991).
1.1.2 Economics
Mastitis is one of the major causes of economic loss to the dairy industry. An 
average of 40 cases of mastitis per 100 cows occurs per year in UK herds and an 
annual incidence of mastitis of less than 30% in any herd is very rare (Esselmont 
and Spincer, 1992; Webster, 1993). Mastitis may present as either clinical or 
subclinical disease, or a combination of the two. It is, therefore, difficult to 
estimate the economic loss as there is an enormous variation within herds in levels 
of clinical and subclinical mastitis, so that a herd may have a high subclinical level 
but a low clinical level or vice versa. An estimate of the prevalence of subacute, 
acute and peracute mastitis cases based on figures suggested by Blowey (1986) is 
70% for subacute cases, 29% for acute cases and 1% for peracute cases. The 
cost of an average case of mastitis in 1992 was £168 with a range of £60.46 to 
£2248, depending on the severity of the case (Esselmont and Spincer, 1992). An 
estimate of the number of dairy cows in the UK in 1991 was 2.6 million (June 
1991, Agricultural and Horticultural Census), and calculations based on the 
prevalence values above, suggest that mastitis costs the UK dairy industry more 
than £100 million each year.
The cost of each episode of clinical mastitis results from: 1). discarded milk, 2). 
cost of intramammary antibiotics prescribed by a veterinarian; 3). the subsequent 
reduction in the milking potential of the affected quarters and poorer quality of 
the milk produced (Blowey and Edmondson, 1995). Antibiotic residues in milk 
and dairy products cannot be completely eliminated by pasteurisation or boiling 
(International Dairy Federation, 1979) and pharmacological legislation requires 
that milk be discarded during treatment and for a specified time period after 
intramammary infusion (Vautier and Postigo, 1986). Mastitis leads to a reduction 
in yield, in lactose and in butterfat content but milk protein levels increase slightly
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with mastitis (Shuster et al, 1991; Blowey et al, 1992). For example, a herd 
with a somatic cell count of 750,000 cells/ml could be losing 750-9001 of milk per 
cow per year, 50g/kg lactose per cow per year and 30g/kg of milk fat per cow per 
year (Blowey et al, 1992). In severe cases of mastitis the costs may include the 
replacement cost of the cow due to premature culling or death during the mastitic 
episode (Esselmont and Spincer, 1992).
Farmers receive financial penalties or premiums based on the level of somatic cells 
in milk and the total bacterial count (TBC) of the milk. Somatic cell counts can 
be measured at the level of the bulk tank, the individual cow or the individual 
quarter.
Bulk milk somatic cell counts (BMSCC) have become universally adopted as a 
screening test for milk quality in herds. They are also useful in creating awareness 
of the existence of a mastitis problem in a herd, so that when a BMSCC exceeds 
permissible levels, further mastitis investigation using more specific techniques is 
often undertaken (Radostits et a l, 1994). The BMSCC is particularly useful as an 
indicator of subclinical infection within a herd (Booth, 1985; Blowey et al, 1992). 
A BMSCC of 250,000 cells/ml is now considered to be a realistic upper limit for 
UK herds with good mastitis control (Blowey et a l, 1992). Field studies in 
Scotland show that the main cause of high BMSCC in herds in Scotland is 
subclinical mastitis, especially when caused by Streptococcus agalactiae and S. 
aureus (Logue et al, 1995).
The individual cow SCC (ICSCC) is an indirect test based on the number of 
somatic cells in a composite sample including milk from all four quarters 
(Radostits et a l, 1994) and has been shown to be the most efficient way of 
identifying high SCC cows (Blowey and Edmondson, 1995). Individual cow SCC 
of less than 250,000 cells/ml are considered to be below the limit indicative of 
inflammation while counts of > 400,000/ml probably suggest the presence of 
infection.
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Individual quarter SCC (IQSCC) is the collection and examination of milk from 
each individual quarter of the udder. Individual quarter SCC exceeding 240,000 
cells/ml are considered to be excessive, although most healthy quarters show less 
than 100,000 cells/ml (Blowey and Edmondson, 1995).
Total bacterial counts in the milk are also used as indicators of intramammary 
infection. In the milk of acute clinical cases the TBC may be as high as 100 
million bacteria/ml, subclinical quarters may contain between 1,000 and 10,000 
bacteria/ml and normal quarters usually yield less than 1,000 bacteria/ml. The 
bulk tank TBC should be ideally < 10,000 bacteria/ml (Blowey and Edmondson, 
1995).
The deregulation of the Milk Marketing Boards in 1994 was the biggest change 
within the UK dairy industry for over sixty years. The UK’s five Milk Marketing 
Boards provided valuable information on national output in the last decade against 
quota; provided technical support, including mastitis control; carried out research 
and development on milk production and negotiated the best selling price for milk 
with the many milk buyers (Sumner, 1994). Under the Milk Marketing Scheme 
there was a barrier between producers and users, and industry management 
decisions were made by the milk boards who represented the producers, which 
resulted in a reduced producer awareness about the market place. On the 1st 
November 1994, the statutory requirement for the Milk Marketing Boards to buy 
all the milk produced was removed allowing direct purchasing from the farmers 
(Pearce, 1995). This allowed purchasers to influence the quality of the product 
and allowed full traceability of the supply to the producer.
The EC hygiene directive was implemented initially in the United Kingdom in May 
1995 by the Dairy Products (Hygiene) Regulations 1995 (1). This replaced the 
existing milk hygiene legislation, The Milk and Dairies (General) Regulations 
1959 (Madders, 1995). The directive sets maximum levels for SCC and TBC in 
milk. Initially this standard is being implemented at the level of bulk consignments 
to milk buyers however, from the 1st July 1997, the standard will apply at 
individual producer level. Supplies with a three month geometric mean SCC
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higher than 500,000 cells/ml and a raw milk TBC of higher than 100,000 over a 
two month geometric mean will become unsaleable. From the 1st January 1998, 
the standard will be a maximum of 400,000 cells/ml with a raw milk TBC of less 
than 100,000 bacteria/ml (Baines, 1996). The implementation of EC 92/46 will 
produce some difficulties for UK milk producers, in particular for the minority of 
producers (approximately 10%), who have a BMSCC consistently over the 
accepted threshold of 400,000 (Logue et al., 1995).
1.1.3 Pathogens
Organisms that cause mastitis can be divided into three main categories depending 
on their pattern of infection, i.e. contagious mastitis, environmental mastitis and 
summer mastitis pathogens (Blowey et al., 1992).
Mastitis pathogens can also be subdivided into major and minor categories. The 
major pathogens are well-recognised as the cause of clinical or subclinical mastitis 
and include organisms such as the contagious pathogen S. aureus and the 
environmental pathogen E. coli (Shukken et al., 1989). The role of minor 
pathogens is less clear with the possibility that they may either cause mastitis 
(Counter, 1981; Shukken et al., 1989) or play a role in protecting the udder 
(Shukken et al, 1989; Nickerson and Boddie, 1994; Pankey et al., 1985; Lam et 
al, 1996).
1.1.3.1 Contagious Pathogens
Primary udder pathogens, including S. aureus and S. agalactiae, are considered to 
be the major causes of contagious mastitis (Webster, 1993). Some authors 
consider S. dysgalactiae to be a contagious pathogen (Hillerton et al, 1995), 
while others believe it should be classed as an environmental, and therefore, 
opportunistic pathogen (Smith et al., 1985; Pankey et a l , 1987; Oliver et a l,
1993). Primary udder pathogens, which are usually transmitted between quarters
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during the milking process, are natural inhabitants of the animals skin or udder, 
and are the predominant cause of subclinical mastitis (Fox and Gay, 1993).
Streptococcus agalactiae is found only within the udder (Fox and Gay, 1993). 
Infection with S. agalactiae causes acute inflammation of the affected quarter 
with clots forming in the foremilk, and often results in an elevation of the animal’s 
temperature. S. agalactiae infection has remained relatively easy to control due 
to the micro-organism’s continued susceptibility to antibiotic treatment 
(McKellar, 1996). Subsequent infections caused by S. agalactiae cause less acute 
inflammation and pain and thus infections may go unnoticed and continue to 
erode the milking capacity of the quarter.
Staphylococcus aureus is a natural inhabitant of the skin and accounts for 25- 
30% of bovine mastitis cases (Sutra and Poutrel, 1993). If the organism 
penetrates the teat sufficiently to cause infection, two main forms of 
staphylococcal mastitis occur (Webster, 1993). The peracute form occurs rarely, 
but usually occurs in early lactation when the defences of the mammary gland to 
infection are at their lowest. Peracute staphylococcal mastitis is extremely severe 
and can often result in the death of the animal within twenty four hours of the 
appearance of clinical signs. Chronic and subclinical infections with S. aureus are 
the most common result of infection (Sutra and Poutrel, 1993). No obvious 
clinical signs of infection or alteration in milk composition occur in subclinical 
cases. However, clots in the milk may be present during chronic infection 
(Radostits et al, 1994). Staphylococci invade deep into the gland (Blowey, 
1990) and can survive and multiply within phagocytes (Sandholm and Mattila, 
1986), resulting in the host defence mechanisms and subsequent antibiotic 
treatment being incapable of completely eliminating the micro-organism from the 
udder. Treatment of staphylococcal mastitis is further complicated by the 
existence of many strains of S. aureus which can cause infection, each with 
variations in sensitivity to antibiotics (Webster, 1993; McKellar, 1996).
Streptococcus dysgalactiae is most frequently transmitted during the milking 
process and is found naturally in the udder and on skin teat lesions (Blowey,
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1990), however, the method of transmission of S. dysgalactaie remains unclear 
(Lam, 1996).
1.1.3.2 Environmental Pathogens
Escherichia coli and Streptococcus uberis are the organisms most frequently 
associated with environmental mastitis (Smith et al., 1985). Environmental 
pathogens are an extremely heterogeneous group of bacterial genera, species and 
strains which are naturally found in the faeces, bedding or on the skin of cows 
(Smith et al., 1985).
The coliform, E. coli, is a natural inhabitant of the large intestine and is found 
surviving in faecal matter (Blowey, 1990). Escherichia coli mastitis can result in 
a wide range of clinical signs varying from mild to peracute cases of mastitis. The 
variation in clinical signs is dependent on the dose of organism and also the stage 
of lactation of the animal (Webster, 1993). In late lactation, or during the dry 
period, only mild infection usually occurs, whereas in early lactation, severe 
infection can result in peracute mastitis associated with a high mortality rate. The 
peracute mastitis caused by E. coli infection is difficult to distinguish from 
peracute contagious mastitis caused by S. aureus (Webster, 1993).
Streptococcus uberis is found naturally on mucous membranes, skin and in the 
faeces (Blowey, 1990) and generally causes less severe infection than E. coli. 
Streptococcus uberis can be isolated from many anatomical sites of the cow 
(Wilson, 1981). A survey of 400 herds in the UK showed that the prevalence of 
udder infection caused by S. uberis was approximately 15% (Wilson, 1981). 
Streptococcus uberis was a frequent cause of new intramammary infection during 
the non-lactating period and under natural conditions, existing infections in the 
dry period may act as the source of infection during lactation (Smith et al., 1985). 
A large proportion of these infections was cleared by the animal shortly after 
parturition, with the organisms remaining sensitive to penicillin when treated 
(McKellar, 1996). Streptococcus uberis is now increasing in importance as a 
cause of mastitis as the levels of contagious mastitis decline (Pott, 1996).
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Summer mastitis generally affects dry cows and heifers at pasture, especially in 
warm humid weather during the months of July to September (Rebhun, 1995). 
Several organisms can be isolated from infected quarters, although the major 
agent is Actinomyces pyogenes which can be isolated in 78% of summer mastitis 
cases (Blowey, 1990). Other organisms involved in summer mastitis include S. 
ciysgalactiae, S. indolicus, and micrococci. Infection is transmitted to the 
damaged teat end by females of the head fly Hydrotea irritans (Webster, 1993). 
Most cases of summer mastitis are acute and severe with generalised toxaemia, 
signs of weakness and fever, and the udder is hard and swollen on palpation 
(Webster, 1993). Most cases of summer mastitis result in severe and permanent 
destruction of the affected quarter or occasionally death of the animal, while less 
severe cases can occur and cause scarring of the sinus and teat canal resulting in a 
blockage of secretion of milk when the cow calves (Radostits etal., 1994).
Other environmental organisms which can cause mastitis include Pseudomonas, 
Klebsiella, Bacillus, Pasteurella species, Enterococcus faecalis and yeasts 
(Radostits et al.t 1994).
1.1.3.3 Minor pathogens
Micro-organisms classed as ‘minor pathogens’ are usually considered to be non- 
pathogenic and occur naturally in ‘normal’ udders (Bramley and Dodd, 1984). 
Minor pathogens include the coagulase negative Micrococcaceae and 
Corynebacterium bovis (Lam, 1996). Minor pathogens have been shown to have 
a potentially protective effect against infections with major pathogenic bacteria 
(Pankey et al., 1985; Nickerson and Boddie, 1994; Lam et al., 1996) and a higher 
prevalence of minor pathogens may be associated with a lower incidence of 
clinical mastitis (Schukken et al., 1989). Minor pathogens have also been shown 
to be associated with cases of clinical mastitis (Counter, 1981; Schukken et al.,
1989) and induce a limited increase in the somatic cell count (Hogan et al., 1987; 
Lam et al., 1996 (b)). While some authors argue that the prevalence of minor 
pathogens, especially coagulase negative micrococcaceae should be reduced
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(Myllys, 1995; Smith and Hogan, 1995), others believe that moderate levels of 
somatic cells induced by minor pathogens may play a role in protecting the gland 
against infection, particularly against coliform bacteria (Lam et al., 1996).
1.1.4 Udder Defences
The bovine mammary gland has many forms of defence against invasion by 
pathogenic organisms, combining non-specific and specific systems, including the 
anatomical features of the gland and the humoral and cellular defence mechanisms 
(Outteridge and Lee, 1988).
The teat duct provides the initial non-specific defence against bacterial 
penetration, acting as both a physical barrier and as a source of antimicrobial 
substances (Outteridge and Lee, 1988). The physical barrier is provided by the 
smooth muscle sphincter surrounding the teat canal which inhibits bacterial 
penetration by maintaining tight closure and limiting bacteria to the teat orifice 
(McDonald, 1975). The teat canal is partially occluded by keratin, a mesh-like 
substance derived from the teat canal lining which inhibits the progression of 
bacteria through the teat duct into the udder (McDonald, 1970). Keratin also 
provides the source of antimicrobial substances including lipids and proteins 
(McDonald, 1970). The importance of the teat duct keratin in protection against 
mastitis was demonstrated by Miller et al. (1991) when removal of 70% of teat 
duct keratin significantly reduced the ability of cows to resist mastitis for two days 
following its removal. Physical variations in teat canal and teat duct have also 
been shown to be important factors in mastitis susceptibility (Lacy-Hubbert and 
Hillerton, 1995).
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1.1.4.1 Humoral Defences
This form of defence can be subdivided into a specific category due to the action 
of immunoglobulins and a non-specific category due to the action of cytokines 
and other proteins. Immunoglobulins form part of the specific humoral defences 
of the mammary gland. The immunoglobulin content of milk and colostrum also 
increases during inflammation (Nickerson, 1985). Immunoglobulins play a role in 
opsonisation and phagocytosis, toxin neutralisation, prevention of bacterial 
adhesion to tissues and direct bacteriolysis. IgGi, IgG2, IgM and IgA have all 
been clearly distinguished in bovine mucosal secretions (Duncan et al., 1972). 
IgGi functions predominantly as an agglutinating, virus neutralising and antitoxic 
antibody (Colditz and Watson, 1985), but can also act as an opsonin (Nickerson, 
1985) and is able to fix complement in vitro (McGuire et al., 1979). IgG2 is 
cytophilic for ruminant neutrophils (McGuire et al., 1979) and has been shown to 
be particularly important in enhancing phagocytosis of S. aureus in cattle 
(Watson, 1976; Guidry et al., 1993). The IgA class of immunoglobulins can 
inhibit binding of bacteria to epithelial tissue and may reduce absorption of antigen 
through the epithelium (Williams and Gibbons, 1972). IgM binds secretory 
component and may be secreted in a similar way to IgA (Butler, 1986). IgM has 
also been shown to play a role in opsonisation of bacteria by neutrophils (Williams 
and Hill, 1982). Immunoglobulin concentration in the mammary gland varies with 
the lactation cycle, the highest concentration occurring near parturition (Concha 
et al., 1980) and at the end of lactation (Guidry et al., 1980).
Non-specific defences include lactoferrin, lysozyme and lactoperoxidase and 
complement (Reiter, 1978). Cytokines may also be included as non-specific 
humoral factors as they can be produced by different types of stimuli, although in 
many cases their production may be induced by cells responding to specific 
immunological stimuli (Wood etal., 1991).
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1.1.4.2 Cellular Defences
Non-infected quarters usually have a SCC of 1-3 x 105 cells/ml milk and during 
infection this can rise to many millions per ml (Nickerson, 1985). The influx of 
bacteria and very high levels of SCC can be measured at 12-24 hours after 
infusion (Hill, 1981; Shuster et al., 1996). A certain level of SCC in the gland 
may in fact be desirable as it is argued that the presence of cells in the secretion 
may in fact be protective against infection (Bramley, 1978). Non-specific 
leucocytosis, induced by the introduction of a polythene loop into the mammary 
gland, an intramammary device, has been shown to cause a mild chronic 
inflammation with maintenance of neutrophils within the gland resulting in a 
decreased likelihood of establishment of infection (Paape and Corlett, 1984). 
Quarters infected with minor pathogens, bacteria which are generally considered 
to be non-pathogenic, show increased resistance to superinfection (Bramley, 
1978; Linde et al., 1980) and attempts to intentionally infect quarters with minor 
pathogens to provide a stimulus to prevent infection against major pathogens have 
been made (Linde et al., 1975; Brooks and Bamum, 1984).
Four cell types are present in normal bovine mammary secretions - neutrophils, 
macrophages, lymphocytes and epithelial cells and the proportion of these cell 
types varies between individuals and depends on the stage of lactation (Lee et al., 
1980). Phagocytosis of foreign material including bacteria is the primary function 
of neutrophils, although they are also involved in many processes including 
modulation of vascular permeability (Wedmore and Williams, 1981) and release of 
inflammatory mediators (Goetzl, 1980). In comparison to blood neutrophils, 
mammary neutrophils are less efficient at phagocytosis. This has been reported 
to be due to prior phagocytosis of casein micelles (Russel and Reiter, 1975) and 
fat globules (Paape and Guidry, 1977). Despite the factors limiting the 
phagocytic activity of mammary neutrophils, this activity is still thought to be the 
primary antibacterial defence mechanism of the mammary gland.
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1.1.4.3 Lymphocytes
The percentage of lymphocytes in cells from mammary secretions are relatively 
constant throughout the lactational cycle (Lee et al, 1980). The presence of both 
T and B cells in bovine milk was suggested by the work of Smith and Shultz 
(1977) as cells isolated from milk were shown to respond to T and B cell 
mitogens. Concha et al. (1978) isolated lymphocytes from milk and showed that 
the proportion of B and T cells was 20 and 45% respectively, similar proportions 
to those found in blood. Smith and Goldman (1968) demonstrated that human 
colostral lymphocytes were responsive to both phytohaemmagglutinin (PHA) and 
specific antigens. B lymphocytes and plasma cells are present in the mammary 
gland tissue and in the teat and play a role in synthesis of immunoglobulins 
(Nickerson and Heald, 1982; Collins et al, 1986). T lymphocytes are involved in 
cell mediated immune response by producing lymphokines that act as 
chemoattractants for neutrophils and macrophages and for stimulating leucocyte 
microbial activity (Craven and Williams, 1985).
1.1.4.4 Macrophages
Cells of the monocyte-macrophage series are the major type in mammary 
secretions for most of the lactational cycle (Watson and Lee, 1978). They are 
also involved in the induction and development of the local immune responses 
(Concha and Holmberg, 1990). Mammary macrophages from involved ovine 
glands (Outteridge and Lee, 1981), lactating women (Mori and Hayward, 1982) 
and cows (Fitzpatrick et al, 1995) have been shown to function as antigen- and 
mitogen-presenting cells in lymphocyte stimulation tests.
In spite of the presence of considerable numbers of immune cells in the local 
mammary gland environment, it has been suggested that the mammary gland is 
generally immunologically compromised when compared to the rest of the body 
(Hurley et al., 1990). The activity of all types of white blood cells in milk, 
neutrophils, lymphocytes and macrophages, have each been shown to be reduced 
compared to cells isolated from blood (Paape et al., 1975). The interaction
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between cells in the local mammary gland environment is also important in 
induction of immunity and failure of cell co-operation is another possible 
mechanism whereby udder defences may be impaired.
1.1.5 Treatment and Control
All dairy farmers are encouraged to practice mastitis control, partly to reduce the 
wastage that the disease causes, but also to contribute to the maintenance of milk 
quality (Radostits et al., 1994). Neave et al. (1969) introduced a standard 
mastitis prevention programme for contagious pathogens which has been 
continuously revised and developed, and has resulted in an approximately 50% 
reduction in udder disease over the past 25 years (Bramley and Dodd, 1984; 
Blowey and Edmondson, 1995). Great progress has been made in mastitis control 
in the UK during this period, mainly due to the uptake of the ‘Five Point Plan’ by 
dairy farmers (Blowey and Edmondson, 1995). The five point plan was outlined 
by the National Institute for Research in Dairying and the Central Veterinary 
Laboratory in 1969 and includes recommendations to: apply an approved teat 
disinfectant after every milking; treat clinical cases of mastitis promptly; infuse 
long-acting antibiotic into all quarters at drying off; test milking machines 
annually; and cull cows showing repeated cases of clinical mastitis (Blowey et al.,
1990).
The five point plan provides an economic advantage, is within the scope of the 
dairyman in terms of technical skill and understanding, can be easily introduced 
into the management system employed, and encourages farmers to persist with the 
plan by rapidly reducing the occurrence of clinical mastitis and the rejection of 
milk by milk processors on the grounds of quality (Blowey et al., 1990).
The use of antibiotic therapy as a control measure for bovine mastitis is not ideal 
due to potential public health risks resulting from the use of intramammary 
antibiotics and the subsequent risk of antibiotic residues in meat and dairy 
products (Vautier and Postigo, 1986). The use of intramammary antibiotics can
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adversely affect manufacturing processes for cheese and cultured milks (Sandholm 
and Mattila, 1986). To enable improved methods of treating and preventing 
mastitis to be developed, the basic defence mechanisms and immune responses 
within the bovine udder should be fully understood. A greater understanding of 
the individual micro-organisms which induce mastitis including strain diversity, 
toxin production, and their subsequent effects on the host should be determined to 
aid the development of future mastitis control programmes.
1.2 The Staphylococci
1.2.1 Genus
The staphylococci have been studied for over a century, during which time their 
pathogenic role in many diseases of man and animals has been established. The 
staphylococci are normally associated with the mucous membranes, skin and skin 
glands of warm blooded animals and are found frequently as aetiological agents 
causing mastitis, food poisoning and different forms of wound and systemic 
infections (Makaya, 1996). Currently the genus Staphylococcus is comprised of 
at least thirty one distinct species (Kloos and Bannerman, 1994). Some common 
staphylococcal species and their natural hosts are listed in table 1.1.
Members of the genus Staphylococcus are facultatively anaerobic, non-motile, 
Gram positive cocci which can occur singly, in pairs or irregular clusters (Kloos 
and Schleifer, 1986; Prescott et al., 1990; Fox and Gay, 1993). The 
staphylococci, like the micrococci, are catalase positive. However, they differ 
from the micrococci in several ways: the staphylococci are oxidase negative, 
ferment glucose anaerobically, have a cell wall composition of peptidoglycan and 
techoic acids, and cell wall DNA with a lower guanidine and cytosine content 
(approximately 30-39% compared with at least 60% in the micrococci) (Prescott 
eta l., 1990).
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Species Coagulase Common, Natural host
S. aureus + primates, humans, mammals, birds
S. intermedius + carnivores, mammals, birds
S. epidermidis humans, domestic animals
S. xylosus humans, birds, domestic animals
S. warneri domestic animals, birds,
S. hyicus + swine, cattle, goats
Table 1.1: Common staphylococcal species and their natural hosts
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The ability of the staphylococci to produce coagulase can be used to divide them 
into pathogenic and relatively non-pathogenic strains (Oeding, 1983). Coagulase 
positive strains often produce a yellow carotenoid pigment and can cause acute or 
chronic infections, whereas strains that do not synthesise coagulase are non- 
pigmented and generally less pathogenic (Prescott et al., 1990). The most 
commonly known and well described coagulase positive staphylococci are S. 
aureus and S. intermedius (Sears et al., 1993). Staphylococcus aureus is one of 
the most common staphylococci isolated from a wide range of animal species, 
either as normal flora or as an aetiological agent associated with purulent 
infections (Matsunaga et al., 1993). The coagulase negative staphylococci make 
up the largest group within the genus and consist of more than thirty different 
species (Aarestrup, 1995). Non-haemolytic, coagulase negative staphylococci 
especially S. epidermidis, S. wameri, S. hyicus and S. xylosus are classified as 
minor mammary pathogens (Radostits et al., 1994). Mastitis resulting from these 
organisms may be subclinical and result in decreased production of milk and an 
elevation in somatic cell count in infected glands (Rebhun, 1995).
1.2.2 Pathogenicity
1.2.2.1 The Staphylococci
A number of factors have been shown to be important in the pathogenicity of 
staphylococci, including the route of infection, enzyme or toxin production and 
components of the bacterial cell wall. The route of staphylococcal infection is 
important in determining the outcome of the invasion of the organism as generally 
only small numbers of staphylococci are required to produce infection of the skin 
or skin glands such as the sebaceous and mammary glands (Blowey et a l, 1992). 
For example, at least 109 colony forming units of some strains of S. aureus are 
required to kill mice by intraperitoneal or intravenous inoculation, whereas only 
nine colony forming units are required to kill mice by intramammary inoculation
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(Anderson, 1986). The immediate availability of milk as a good growth medium 
as well as the absence of sufficient numbers of phagocytic cells, until they are 
recruited by chemotaxis, allows rapid multiplication of the staphylococci within 
the mammary gland (Anderson, 1986).
Staphylococci induce infection through their ability to multiply and spread widely 
in tissues, which is aided by their production of many extracellular substances 
such as exotoxins or enzymes which are thought to be involved in invasiveness 
(Kotzin et al, 1993; Lee, 1996). The pathogenicity of the staphylococci is related 
mainly to their synthesis of toxins such as haemolysin, leucocidin and enterotoxin, 
or of enzymes such as coagulase, hyaluronidase and penicillinase (Anderson, 
1986). The function of these extracellular enzymes and toxins should be 
considered not only as destructive to the host, but as advantageous to the 
invading organism in providing low molecular weight nutrients for bacterial 
growth (Anderson, 1986; Makaya 1996). Coagulase, hyaluronidase, 
phosphatases, DNAase, proteinases, lipase, catalase, lactate dehydrogenase and 
penicillinase are the most frequent enzymes produced by the staphylococci, 
however, while not all enzymes are produced by every strain, every strain does 
produce catalase (Prescott et al, 1996). Most of the enzymes are produced in the 
late logarithmic phase of growth with the exception of coagulase which is 
produced during early exponential growth (Arvidson, 1983). The main toxins 
produced are leucocidin, exfoliative toxin, toxic shock syndrome toxin (TSST-1), 
haemolysins and enterotoxins (Wood et al, 1991; Kenny et al, 1993). The 
enterotoxins are membrane-damaging exoproteins which can be divided into 
several different types, designated staphylococcal enterotoxins A-E (Wood et al, 
1991; Orden et al, 1992). The function of alpha toxin, one of the enterotoxins, 
and leucocidin, is directed towards the destruction of cells and lysis of neutrophils 
(Anderson, 1986; Prescott et al, 1990).
Several other substances which are involved in resistance to phagocytic ingestion 
are found within the cell wall structure of the staphylococci. Protein A binds 
immunoglobulin via the non-specific Fc receptor rather than the antigen specific 
Fab terminal and thus activates complement which increases the resistance of the
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staphylococci to phagocytic ingestion by masking the immunoglobulin Fc sites 
(Greenberg et al., 1987; Roitt et al., 1993; Lee, 1996). Peptidoglycan which is 
the major component of the staphylococcal cell wall can induce a number of 
endotoxin like effects, including pyrexia (Adlam and Easmon, 1983).
1.2.2.2 Staphylococcus aureus
Staphylococcus aureus is a particularly well adapted pathogen for the mammary 
gland (Pott, 1996). It frequently causes clinical mastitis, which is mainly a 
sporadic disease resulting from chronic subclinical infection.
The pathogenic capacity of a particular strain of S. aureus is due to the combined 
effect of extracellular factors and toxins, together with the invasive properties of 
the strain (Prescott et a l, 1990). S. aureus produces around thirty extracellular 
proteins, some of which have been shown to be virulence factors. Matsunaga et 
al (1993) compared the distribution of virulence factors among S. aureus isolates 
from peracute, acute and chronic bovine mastitis cases and correlated the results 
with clinical presentation. These authors concluded that all S. aureus isolates 
from peracute cases produced TSST-1, staphylococcal enterotoxin C, alpha- 
haemolysin and beta-haemolysin, whereas none of the peracute isolates produced 
clumping factor or protein A, which were associated with chronic mastitis. 
However, there was no obvious variation in virulence factor production between 
isolates from acute cases or isolates from chronic cases which is in agreement 
with the findings of Jonsson and Holmberg (1981).
The initial line of defence against staphylococcal infection is the physiologically 
normal and intact skin. In terms of infection of the udder, the action of the teat 
duct sphincter (McDonald, 1975) and the antibacterial properties of the keratin 
lining the teat duct play an important role. Mechanisms such as flushing of the 
udder during milking also aid in preventing infection (Anderson, 1986). 
Attachment to ductal epithelial cells is an important step in colonisation of the 
mammary gland and surface epitopes are likely to be involved (Blowey et al, 
1992; Makaya, 1996). Antibody has been shown to play a role in preventing
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adherance of bacteria to mammary gland epithelial cells (Kenny et al, cited in 
Blowey et al., 1992). Once the outer skin defences of the host are breached the 
staphylococci are killed almost exclusively by the phagocyte-opsonin system 
(Anderson, 1986). Many staphylococcal products are directly or indirectly 
chemotactic for neutrophils and macrophages (Kenny et a l, 1993). However, in 
small quantities, alpha toxin, leucocidin and peptidoglycan may be antichemotactic 
(Craven and Williams, 1985). Recruitment of neutrophils is generally not 
impaired, and ingestion by phagocytes is not a limiting factor as long as 
recruitment of neutrophils is sufficiently fast (Craven and Williams, 1985). The 
migration of neutrophils from the blood into the udder, involves the cells passing 
through the blood-milk barrier and is activated by chemotaxis (Kremer et al,
1990). Once the neutrophils have passed into the milk in response to chemotaxis, 
they engulf the invading micro-organism. Inside the neutrophils, bacteria are 
destroyed by a system involving hydrogen peroxide (Blowey and Edmondson,
1995). Staphylococci are killed by neutrophils by discharge of the granular 
contents into phagosomes (Lee, 1996). Staphylococcus aureus avoids elimination 
from the udder by employing a number of features including the ability to survive 
inside white blood cells and to outlive these cells and thus survive within the 
udder. Host inactivation of strains of S. aureus is a delicate balance between 
staphylococcal growth and the phagocyte-opsonin system, and usually this 
balance reaches equilibrium at the level of intracellular survival of the 
staphylococci, which is a typical feature of chronic staphylococcal mastitis in 
cattle (Anderson, 1982). The inability of phagocytes to kill all intracellular 
staphylococci is not fully understood and may relate to the exhaustion of 
bactericidal substances, the metabolic dormancy of the organism or the low pH of 
the phagocytic vacuole (Rebhun, 1995). The development of methods to kill all 
intracellular staphylococci remains one of the most important and urgent problems 
in staphylococcal research (Anderson, 1986).
Abscess formation and fibrosis associated with staphylococcal infection reduces 
phagocyte infiltration and prevents antibiotic penetration, with multiple micro­
abscesses forming throughout the mammary tissue in chronic mastitis (Sears and 
Heider, 1981; Makaya, 1996). When ingestion of invading organisms occurs,
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many staphylococci are killed by the neutrophils, however sufficient levels of 
alpha toxin may have been produced to lyse the phagocytes and cause necrosis of 
the adjacent tissue (Anderson, 1986).
A major limitation in the effective control of staphylococcal mastitis remains its 
poor response to antibiotic therapy. There are a variety of reasons for this of 
which antibiotic resistance plays only a minor role (McDonald and Anderson, 
1981; Newman et al., 1985; Craven, 1987). The ability of bacteria to survive 
inside polymorphonuclear neutrophils, macrophages and epithelial cells, where 
they are protected from the action of certain antibiotics, may also contribute to 
their resistance to therapy (Sandholm and Mattila, 1986; Blowey et a l, 1992). At 
present, staphylococcal infections are treated most successfully with a bactericidal 
antibiotic such as the semisynthetic penicillins which have some ability to 
penetrate intracellular organisms surrounded by dense tissue (Anderson, 1986). 
However, Madgwick et a l (1989) concluded that penetration of certain 
antibiotics into bovine neutrophils can be altered by the presence of ingested 
staphylococci, and that high intracellular levels of antibiotics does not necessarily 
ensure effective intracellular activity against pathogenic micro-organisms.
Vaccination against staphylococcal bovine mastitis has been attempted but has 
met with limited success (Slanetz et al., 1963). A S. aureus mastitis vaccine is 
commercially available in the United States of America which has been shown to 
cause decreased prevalence of S. aureus positive milk cultures and decreased 
persistence of intramammary infection following experimental infection (Williams 
et al., 1966; Williams et al., 1975). Anderson (1986) suggests that no single 
virulence determinant has been identified from which a vaccine against 
staphylococci can be developed. Many virulence factors play a role in the 
pathogenesis and, therefore, antibodies against them may have only a partial role 
in protection. Development of a multi-component vaccine comprising of capsular 
polysaccharide complexed with either a toxoided staphylococcal toxin or with a 
surface protein known to be important in colonisation of the mammary gland 
epithelial cells has been suggested by Foster (1991). The multiplicity of virulence 
factors produced by S. aureus in addition to this organisms ability to evade the
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host immune system by a variety of mechanisms has resulted in S. aureus being a 
common mastitis pathogen which is particularly difficult to treat and control.
1.2.3 Identification
1.2.3.1 Methods
Species identification of a microorganism is important for diagnosis, treatment 
and prevention of disease. Identification and additional typing can be carried out 
on the basis of growth characteristics of an organism on selective media, the 
recognition of microbial antigens by monoclonal or polyclonal antibodies, 
antibiotic susceptibility, biochemical characteristics, susceptibility to infection by 
bacteriophages and general features such as odour and colony formation in 
addition to molecular typing techniques (van Belkum, 1994).
In bacterial typing, the reliability of a typing system depends on the bacterial 
characteristic on which the typing method is based. The choice of the 
characteristic depends on its stability within a strain and its diversity within a 
species (Eisenstein, 1990; Brown, 1991). Methods used for discrimination of 
strains within a species can generally be divided into phenotypic and genotypic 
procedures. The use of conventional phenotypic and molecular genotypic typing 
methods as epidemiological tools help in understanding infectious diseases (Kapur 
et al., 1995). Control of communicable diseases, such as mastitis, can be 
improved by the use of typing methods which define sources of infection, 
mechanisms of transmission, and rates of spread within a population (Makaya,
1996).
Phenotypic procedures take advantage of biochemical, physiological and 
biological phenomena, whereas genetic procedures aim to detect polymorphisms 
at the level of nucleic acids or to detect allelic variation at the level of enzymes 
(Kapur et al., 1995). Some of the commonly used conventional phenotypic
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methods include antibiogram typing (Aarestrup et al., 1995 (c)), biotyping 
(Devriese 1984), serotyping and phage typing (Guinee and Van Leeuwen 1978; 
Lipman et al., 1996; Makaya, 1996). These biological tests are laborious to 
perform and require sophisticated reagents which are often not commercially 
available. However, these methods can provide adequate epidemiological 
analyses of various organisms. Alternatively, protein analysis can be used to 
delineate the origin of a strain of microorganism and to establish relationships 
among isolates (Eisenstein, 1990). Techniques such as whole-cell protein 
profiling, outer membrane profiling, isozyme electrophoresis and various 
immunoblotting techniques are frequently employed (Eisenstein 1990). 
Phenotypic procedures are generally not used for discrimination between strains 
of different species, whereas genetic procedures are preferred when strain 
differentiation is required (van Belkum, 1994).
Genotypic methods are systems which have been developed more recently for use 
in bacterial typing. These methods are based on less environmentally influenced 
genetic bacterial elements, and as such, they have a higher typability, 
reproducibility and discriminating power compared to the phenotypic methods 
(Makaya, 1996). Commonly used genotypic methods are plasmid profiling 
(Aarestrup etal., 1995 (c)), direct sequencing of DNA fragments, or variations of 
restriction fragment length polymorphism techniques such as ribotyping 
(Aarestrup et al., 1995 (b)), pulsed field gel electrophoresis, polymerase chain 
reaction (PCR) -digest and random amplification of polymorphic DNA fragments 
(Wolcott, 1992; Olsen et al., 1993; Matthews et al., 1994; Aarestrup, 1995; 
Rantamaki and Muller, 1995; Lam et al., 1996; Lipman et al., 1996). However, 
genetic typing assays also have drawbacks. In general these procedures require 
relatively large amounts of high quality DNA or RNA and a high degree of 
technical skill. Therefore, simple procedures such as PCR, in which small 
amounts of relatively impure nucleic acid is required have been developed (van 
Belkum, 1994). PCR typing provides the potential to analyse most of the 
medically important organisms by a single technique. The bacterial genome 
harbours repetitive sequences that can be used for DNA typing (Versalovic et al., 
1993; Lupski and Weinstock, 1992). The characteristics of these sequences are
23
their restricted length and their widespread occurrence. Prokaryotic repetitive 
motifs occur throughout the entire genome but rarely within genes. Repeats were 
initially discovered in E. coli and Salmonella typhimurium (Higgins et al., 1982; 
Gilson et al., 1989), and were later identified in several other bacterial species. 
PCR assays aiming at prokaryotic consensus repeats, arbitrary sequences or 
sequences of the methicillin resistance gene complex detected nearly twice as 
much variation as phage typing, indicating that PCR fingerprinting enabled the 
detection of genetic variants in the homogeneous phage groups (van Belkum, 
1994).
1.2.3.2 The Staphylococci
DNA restriction endonuclease fingerprinting (REF) measures restriction fragment 
length polymorphism and has been developed for many pathogens including the 
staphylococci (Bumie and Lee, 1988; Bialkowska-Hobrzanska et al., 1990). 
Jayarao et a l (1991) reported that DNA REF was an effective method for 
differentiating closely related and unrelated strains of S. uberis isolated from 
bovine mammary secretions, which was in agreement with studies by Christ et al. 
(1988) and Hill and Leigh (1989). Another study by Matthews et al. (1992) 
examined 51 staphylococcal isolates by REFP and antibiogram typing and 
concluded that DNA REFP anlaysis successfully differentiated closely related 
strains of each species isolated. The ease by which REF analysis can be 
performed together with the reproducibility and clarity of REF patterns suggest 
that this technique is useful in the differentiation of closely related and unrelated 
strains of staphylococci isolated from bovine mammary secretions (Matthews et 
a l , 1992).
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1.2.3.3 Staphylococcus aureus
Many phenotypic and genotypic methods have been used to study S. aureus strain 
diversity in cases of bovine mastitis (Fox et al., 1990; Roberson et al., 1994; 
Aarestrup e ta l., 1995 (b); Lam et al., 1996). A staphylococcal biotyping system 
was developed which differentiated S. aureus strains from man and animals into 
host-specific ecovars and biotypes which were not host-specific (Devriese, 1984). 
Problems with biotyping include the strict need for adherence to the described 
methods in order to obtain reproducible results. Multilocus enzyme 
electrophoresis (MLEE) has been used extensively to index allelic diversity among 
human and animal pathogens including the staphylococci. (Matthews et al, 
1994). Kapur et a l (1995) typed 90% of S. aureus isolates using MLEE, and 
clearly demonstrated the presence of genetic heterogeneity among strains isolated 
from a single herd. MLEE provides data from which statistical estimates of 
genetic diversity and overall chromosomal relationships can be obtained, however, 
levels of discrimination are often too low to be of epidemiological value when 
used alone.
Phage typing and genotyping by PCR using RAPD, ERIC1R and ERIC primers 
was used to differentiate 71 S. aureus strains isolated from bovine mastitis 
(Lipman et al., 1996). The RAPD primers gave the most significant DNA 
polymorphism changes, with phage typing yielding no more additional 
information. ERIC primers were used to compare DNA polymorphism patterns 
of different isolates and identified 11 genotypes within 63 S. aureus isolates from 
five herds in a study carried out by Lam et al. (1996). Matthews et al. (1994) 
also used a PCR based DNA fingerprinting technique to type 75 S. aureus isolates 
into 19 distinct profiles and these authors concluded that this technique 
differentiated closely related strains within and between geographic locations.
PCR has been shown to be a reliable and practical method for identification of 
isolates associated with bovine mastitis although few publications describing the 
use of PCR in S. aureus mastitis are available. The genotype differentiation of S.
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aureus strains is thought to be one of the most accurate methods to date (Wang et 
al., 1993). Compared to existing typing methods, PCR based DNA fingerprinting 
is easy to perform and interpret (Matthews et al., 1994), with only Saulnier et al. 
(1993) reporting that pulse-field gel electrophoresis was more discriminating. 
Most authors conclude that ribotyping is the most discriminatory typing method 
followed by biotyping and phage typing which can have a low level of 
discrimination due to the low typability of some bovine strains (Aarestrup et a l, 
1995 (c, d); Makaya, 1996). Using more than one phenotypic or genotypic typing 
method for strain biotyping improves the discriminatory powers. Development of 
methods allowing maximum discrimination among S. aureus isolates should help 
in further understanding the ecology of these pathogens and the epidemiology of 
mastitis caused by them.
1.3 Inflammation
Mastitis is clinically recognisable by pain and inflammation of the udder (Webster, 
1993). The heat and redness often associated with mastitis is caused by an 
increase in blood flow accompanied by leakage of cells and fluids into the tissues 
resulting in increased pain within the infected area (Janeway-Travers, 1994). 
Inflammation is a result of dilation of local blood vessels in conjunction with 
increased permeability to leucocytes and is a complex response to tissue injury. 
The response can be either local or systemic, or a combination of the two (Evans 
and Whicher, 1992). The main cell types involved in the inflammatory response 
are the polymorphonuclear neutrophilic leucocytes, macrophages, monocytes and 
a small proportion of lymphocytes (Gruys e ta l,  1993; Travers, 1994).
Inflammation may be initiated in various ways through different pathways (Evans 
and Whicher, 1992). Simple trauma activates mast cells which release mediators 
to control vasodilation, vascular leakage and, in some circumstances, proteolytic
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activation of biochemical mediator systems such as complement (Roitt et al., 
1993). The inflammatory response can be triggered directly by pathogens, 
especially in early infection where bacterial pathogens are the main initiating 
factors (Vander et al., 1994). During the initial stages of infection, the 
inflammatory response is essential in attracting the non-specific inflammatory cells 
such as monocytes and neutrophils to the site of infection, where these cells 
release inflammatory mediators which activate other components of the immune 
response (Bomstein, 1982; Marinkovic et al., 1989; Travers, 1994). The cellular 
processes of inflammation fall into four major groups: 1). changes in blood flow 
caused by changes in smooth muscle cell function resulting in vasodilation; 2). 
alterations in vascular permeability caused by cytoskeletal contraction in 
endothelial cells; 3). migration of phagocytic leucocytes to the site of 
inflammation; 4). phagocytosis (Roitt etal., 1993).
1.3.1 Acute Phase Response
The acute phase response (APR) in animals is a result of tissue damage and is 
particularly associated with inflammation (Eckersall and Conner, 1988). In 
addition to the local responses described above, there is also a systemic APR, 
which encompasses the animals initial reaction to infection, inflammation or 
trauma (Skinner et al., 1991). The term ‘acute phase’ was introduced by Avery et 
al. as early as 1941. The APR is a non-specific response which commences 
within a few hours of infection, can last for several days and includes pyrexia, 
cachexia, and variations in serum hormone, trace element and protein 
concentrations (Eckersall, 1992 (b)).
The APR is controlled by a complex array of cytokines and hormones which 
produce multiple effects such as fever, lethargy, muscle proteolysis and 
leucocytosis (Evans and Whicher, 1992; Eckersall, 1992 (b)). The APR is 
initiated by cytokines such as interleukin-1 and interleukin-6 produced by white 
blood cells which alter the regulation of proteins secreted by the liver into the
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bloodstream, with IL-6 acting specifically on hepatocytes (Janeway-Travers, 
1994; Vander et al., 1994). The APR is thought to be beneficial to the injured 
animal in acting to restore homeostasis and prevent microbial growth (Koj, 1974; 
Pepys and Baltz, 1983; Gruys et al., 1994) and has been identified in cattle by 
measurement of acute phase proteins (APP) in a variety of clinical conditions such 
as salmonellosis, mastitis, acute severe metritis, pneumonia and traumatic 
pericarditis (Eckersall, 1992 (a)).
1.3.2 Acute Phase Proteins
During the APR a major alteration is found in the liver where the hepatocytes are 
stimulated to increase production and secretion of several plasma proteins 
(Vander et al., 1994). These are termed positive acute phase proteins and 
increase in concentration in the serum during the APR. The hepatocytes also 
regulate the secretion of albumin, a negative APP, which decreases in 
concentration during the APR, along with several other negative APP such as 
transferrin (Eckersall and Conner, 1988; Gruys et al., 1994). The APP, including 
haptoglobin, serum amyloid A (SAA), alpha-1-anti-trypsin, ceruloplasmin and 
fibrinogen are mainly glycoproteins secreted by the liver in response to IL-6, IL-1 
and TNFa produced by leucocytes and macrophages during infection and 
inflammation (Bomstein, 1982; Laurell, 1985; Marinkovic, 1989). Regulation of 
synthesis of the APP appears to be a highly complex process which is modulated 
or controlled by several cytokines. The major cytokines IL-6, IL-1, TNF-a, 
interferon y, leukaemia inhibitor factor and transforming growth factor-p, alone, 
or in combination, have been shown to influence the serum concentration of the 
acute phase proteins (Maurhaug and Dowton, 1984). Acute phase proteins have 
many roles within the body ranging from acting as scavengers, promoting 
immunoglobulin production or involvement in tissue repair (Whicher and Dieppe, 
1985). As the circulating concentration of these proteins reflects the presence or 
extent of infectious or inflammatory lesions they can be used as markers of disease 
(Eckersall, 1992 (a)).
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Acute phase proteins are classified according to the degree of increase in serum 
concentration as either major, moderate or minor APP: for example, in humans C- 
reactive protein (CRP) is classed as a major APP, as the serum concentration of 
CRP increases from a very low level of less than lmg/1 to a concentration of 
greater than 200mg/l within twenty four hours (Kushner et al., 1978; Roitt et al., 
1993), whereas a moderate APP in humans, such as alpha-1-anti-trypsin, has only 
a 2-3 fold concentration increase within 3-5 days of infection (Eckersall, 1992 
(a)). Major APP are useful markers of inflammation if they have negligible or low 
basal values with a narrow reference range which remains unchanged with age, 
sex, or genetic make-up of the animal. The concentration of a major APP should 
increase rapidly to very high levels (>100 times) in response to infection or 
inflammatory conditions, with the level of response ideally equivalent to the 
amount of tissue damage sustained (Kent, 1992). Non-inflammatory conditions, 
nutritional status, exercise, handling or other forms of minor stress should ideally 
not affect APP concentration, whereas a secondary infection or relapse in the 
inflammatory condition should result in an increase in plasma concentration of an 
APP being used to provide diagnostic information (Kent, 1992).
Major APP vary with species, in humans CRP and SAA are major APP 
(Pepys,1979), whereas CRP appears to be a normal constituent of bovine serum 
(Maudsley, 1985). In general, the APP of the dog and cow are similar to those in 
man, however significant differences do exist (Eckersall, 1988). As in man, 
canine CRP is a major APP with a normal serum concentration of less than 5mg/l 
increasing to over 200mg/l during the APR (Eckersall, 1988). Fibrinogen is 
probably the most universally measured APP in animal plasma (Schlam, 1970), 
however, it is not a major APP in many animal species, with the most accurate 
assay procedures being unsuitable for rapid analysis (Laurell, 1985). Haptoglobin 
is a major APP in cattle with a low basal level which increases dramatically during 
the APR, yet haptoglobin is a constitutive plasma protein in dogs and humans 
(Eckersall, 1988). Levels of haptoglobin have been shown to double in dogs and 
humans following surgery (Conner et al., 1988). Haptoglobin and SAA are major 
bovine APP (Eckersall and Conner, 1988; Gruys eta l.y 1994).
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The time course of the APR also varies considerably with the APP studied. In 
humans, SAA and CRP increase in concentration very rapidly within hours of the 
initial infection, reaching maximum levels in 1-3 days and rapidly resuming basal 
levels after the APR has been controlled (Kushner, 1982; Emery and Luqmani, 
1993). In contrast, fibrinogen may not reach maximum serum concentration until 
two weeks after the initial APR and requires a further seven days to return to 
normal levels (Blackburn, 1994). In cattle, SAA has been shown to become 
elevated in both spontaneous and induced APR within eight hours of infection 
(Alsemgeest et al., 1993).
In addition to using APP levels as markers of disease in the live animal, 
measurement of APP may also be useful during meat inspection, for detecting 
infected carcasses (Saini and Webert, 1991). Many of the conditions which cause 
condemnation of meat are also conditions which would be likely to produce an 
APR and thus an elevation of the relevant APP (Saini and Webert, 1991). The 
assessment of APP of animals at slaughter could enable detection of the presence 
of inflammatory lesions in the carcasses and form an important element of future 
quality assurance schemes (Eckersall, 1992 (b)).
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1.3.3 Major Acute Phase Proteins of Cattle
1.3.3.1 Haptoglobin
Bovine haptoglobin is a highly polymerised serum haemoglobin binding protein 
which has been identified as an acute phase reactant in cattle (Morimatsu et al.,
1992). Levels of haptoglobin increase in sera after inflammatory stimuli and has 
resulted in haptoglobin being used as an indicator of a variety of inflammatory 
conditions (Eckersall, 1988; Morimatsu et al., 1992). The rapid increase in 
haptoglobin concentration provides the basis for the usefulness of haptoglobin in 
the early detection of the APR (Skinner et al., 1991). Bovine haptoglobin differs 
considerably from human haptoglobin in terms of physiology and immuno- 
reactivity and is a major APP which is normally absent or present at low 
concentration in serum (Eckersall and Conner 1988).
Haptoglobin concentration in bovine serum was originally expressed as a 
percentage of haemoglobin binding capacity based on the ability of haptoglobin to 
bind haemoglobin and preserve peroxidase activity at low pH. However the 
purification of bovine haptoglobin by Eckersall and Conner (1988) has now 
allowed the quantification of serum haptoglobin in grams per litre. The use of the 
haptoglobin-haemoglobin assay in routine testing of bovine plasma is useful in 
monitoring the APR, however, as the function of haptoglobin is to bind and 
remove free circulating haemoglobin, the interpretation of results has to be 
cautious when a potential haptoglobin response is accompanied by haemolytic 
disease, when inaccurate results may be obtained (Eckersall, 1988; Skinner et al.,
1991). In vitro, the formation of the haptoglobin-haemoglobin complex is 
followed by the removal of this complex by the liver, resulting in reduced 
haptoglobin levels. One advantage of the haptoglobin assay over other APP 
assays is that it can be performed quickly and accurately and may, therefore, be 
preferable to an assay for other major acute phase proteins, such as SAA, which 
have lengthy and technically demanding assay procedures (Skinner et al., 1991).
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Several other assays for detecting elevation in haptoglobin values have been 
developed involving single radial immunodiffusion (Morimatsu et al., 1992) and 
high performance liquid chromatography (Salonen et al., 1996). These methods 
have also been shown to have improved sensitivity compared to the routine 
haptoglobin-haemoglobin assay, but are still affected by removal of haptoglobin in 
haemolytic conditions.
In serum of healthy cattle the normal level of haptoglobin is less than 0.10g/l, with 
the concentration increasing up to 100-fold within twenty four hours of infection 
(Conner et al., 1988). The increase in bovine haptoglobin concentration from a 
basal level of less than 0.10g/l to greater than 4.00g/l within 48 hours of infection 
may indicate the severity of the physical stress or inflammation in diseases such as 
mastitis, pyometra and traumatic reticulitis, and as such, may be a valuable aid in 
diagnosis of clinical disease (Makimura and Suzuki, 1982; Skinner et al., 1991).
1.3.3.2 Serum Amyloid A
Serum amyloid A was initially recognised in serum due to its cross-reactivity with 
antisera to the amyloid AA protein isolated from deposits of secondary amyloid 
(Levin et a l 1973; Husby and Natvig, 1974). Serum amyloid A is a trace level 
constituent of normal serum found in the circulation bound to the high density 
lipoprotein apoSAA, and is a very sensitive APP which increases up to 1000 fold 
after tissue damage and infection in cattle, horses and humans (Kushner, 1982; 
Maurhaug, 1983; Alsemgeest e ta l,  1993; Horodagoda, 1994).
Serum amyloid A has been identified as a very heterogeneous protein in all species 
studied to date and is regarded as representing a family of 12kDalton molecules 
with 104-112 amino acid residues, with a possible insertion of 8 amino acids at 
position 72 (Betts et al., 1991). Bovine SAA has 112 amino acid residues and 
contains a 9 amino acid insertion between positions 69 and 70 (Rossevatn et al.,
1992). The majority of the SAA isotypes are involved in the APR while others 
are constitutive proteins (Whitehead et al., 1992). All types of SAA are 
transported in serum as apoproteins in the high density lipoprotein (HDL) fraction
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(Benditt and Eriksen, 1977). The association of SAA and HDL is likely to occur 
following the secretion of the SAA (Hoffman and Benditt, 1982), and in most 
species, two structurally similar SAA isotypes are expressed in the liver, while a 
structurally different form of SAA is independently regulated and expressed 
primarily in the extrahepatic tissues (Maurhaug and Dowton, 1984). The increase 
in serum concentration of SAA during inflammation is due to both the increase in 
synthesis and decrease in degradation of the SAA by the liver (Maurhaug and 
Dowton, 1984).
The function of SAA remains unclear, with original studies by Aldo-Benson and 
Benson (1982) indicating that SAA may be influencing lymphocyte responses to 
antigens. Other authors have suggested that the function of SAA is to redirect 
HDL to inflammatory cells such as macrophages, or to aid in cholesterol removal 
(Kisilesky, 1991). The former theory has been supported in studies which showed 
that when SAA is bound to the HDL portion, the affinity of HDL for 
macrophages increases 2-3 fold. Atherosclerotic lesions possess many features 
similar to those found in inflammatory reactions, however the role of SAA in 
pathogenesis remains unclear (Maurhaug and Dowton, 1984). Studies by 
Shainkin-Kestenbaum et a l (1991) have indicated that a possible feedback system 
may exist between SAA and the immunoregulatory cytokines, and as SAA 
increases in concentration after tissue destruction, a role in normal tissue repair 
may also occur.
Serum amyloid A is the most sensitive APP characterised to date, in both humans 
and many animal species, and has been used in the diagnosis and monitoring of 
inflammatory and infectious diseases. An increased concentration of SAA has 
also been associated with amyloidosis in the dog, mink, cat, rabbit, horse and 
cattle (Hoi and Gruys, 1984). Serum amyloid A has been identified as the major 
APP in the horse and has been shown to be a reliable marker for assessment of 
tissue damage during training and racing (Pepys et al., 1989). Recently SAA has 
been identified as an APP in cattle (Boosman et a l, 1990; Alsemgeest et a l,
1993) and monitoring bovine SAA concentration may serve as a specific and 
reliable marker for clinical inflammation and tissue injury (Boosman et a l,  1990;
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Alsemgeest et al., 1993). However, due to the unavailability of a rapid automated 
assay, the use of SAA as a routine indicator of inflammation has been limited 
(Maurhaug and Dowton, 1984). Measurement of SAA in cattle is hampered by 
the difficulty in isolation of the SAA when dissociated from the HDL fraction and 
also the poor immunogenicity of the protein for the production of antiserum 
(Eckersall, 1992 (a)).
Other problems in the development of a SAA assay have been lack of standards 
and monospecific antibodies for SAA (Maurhaug and Dowton, 1984). Improved 
methods for purification of SAA and the introduction of monoclonal or polyclonal 
antipeptide antibodies have aided in the development of current assays for human 
SAA (Casl and Grubb, 1993; Wilkins et al., 1993).
The regulation of SAA and haptoglobin appear to be disease specific pathways. 
Serum amyloid A was found to be an indicator of acute inflammatory lesions, 
whereas haptoglobin indicated more chronic pathology (Alsemgeest et al., 1994). 
In human disease, SAA is a more sensitive indicator of inflammation than 
haptoglobin but studies in cattle have been limited due to the non-availability of a 
robust SAA assay. In man, the assay of APP has become an accepted and useful 
diagnostic aid for the detection and monitoring of conditions leading to an APR 
(Kushner and Mackiewicz, 1987). The development of APP detection assays in 
the assessment of the chronicity and severity of disease in cattle has considerable 
potential for diagnosis and prognosis. Limited studies have shown that the 
circulating concentration of bovine SAA correlates with the level of severity of 
disease status i.e. acute, subacute or chronic (Gruys et al., 1994; Horadogoda et 
al., 1994). In clinical diagnosis in cattle the levels of APP may aid in monitoring 
diseases such as hepatic lipidosis, inflammatory processes and periparturient 
diseases especially when both haptoglobin and SAA are measured (Gruys et al.,
1993).
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1.3.4 Mammary secretions
1.3.4.1 Inflammation
Measurement of the SCC is an indirect test used routinely in the analysis of milk 
as an indicator of bovine mastitis (Sears and Heider, 1981). Indirect tests which 
determine alterations in milk composition, enzyme concentration and serum 
protein levels can also be used as indicators of inflammation (Huszenicza and 
Stollar, 1993). The NAGase test is based on the measurement of the cell 
associated enzyme N-acetyl-(3-D-glucosaminidase and is reputed to be the most 
accurate of the indirect tests and as accurate as SCC in predicting the infection 
status of a quarter (Pyorala, 1988). Other indirect tests such as the estimation of 
serum albumin concentration, is indicative of damage to the mammary mucosa 
and increases according to the epithelial damage sustained (Radostits et al,
1994). The antitrypsin test which measures the trypsin-inhibitor capacity of the 
milk has also been extensively used in diagnosis (Radostits et a l, 1994). The 
diagnosis of both clinical (Shuster et al., 1991; Huszenicza and Stollar, 1993) and 
subclinical mastitis has been carried out using these methods of detection 
(Nizamilioglu et al., 1989).
1.3.4.2 Acute Phase Response and Acute Phase Proteins
Limited work has been performed to date on the detection of the APR and APP in 
mammary secretions. Schroldt et al. (1995) described the first detection system 
for the APP CRP in milk as a novel indicator of bovine mastitis. Milk samples 
taken from healthy and mastitic cows gave CRP concentrations ranging from 65- 
103ng/ml and 93-417 ng/ml respectively. In some cases, as much as a tenfold 
increase in CRP levels was observed in milk following inflammation of the udder, 
suggesting the potential usefulness of CRP as an indicator of mastitis. CRP 
however is generally not considered as a major APP in bovine or equine serum 
(Kent, 1992). Levels of cti anti-trypsin, which is only a moderate serum APP in
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the bovine, have also been shown to increase in serum and milk of cows with 
mastitis (Honkanen-Buzalski et al., 1981; Sandholm et a l, 1984). The 
concentration of GCi anti-trypsin was related to the presence of serum albumin and 
increased SCC in milk: as the severity of the mastitic attack increased, the levels 
of cti anti-trypsin in milk also increased, by 100 fold, while in some animals only a 
4 fold increase was detected in serum (Honkanen-Buzalski et al, 1981).
Acute phase protein assays may provide a valuable aid to prognosis and early 
diagnosis of conditions such as bovine mastitis (Conner and Eckersall, 1986), and 
detection of the major bovine APP, SAA and haptoglobin in milk may also form a 
part of future quality assurance schemes. Of these two APP, SAA would be the 
better analyte to quantify as it is not effected by haemolytic conditions and is more 
responsive to stimulation than is haptoglobin (Horadogoda et al, 1994).
1.4 Aims of the Project
The overall aim of this project was to study infection and inflammation in 
experimentally-induced S. aureus mastitis in cows. A novel double-cross over 
design was employed for experimental intramammary challenge in this study. 
Udder quarters, with naturally-occurring subclinical mastitis caused by S. aureus 
were challenged by the intramammary route with very high numbers of either the 
indigenous or non-indigenous strain of S. aureus.
In studying infection due to S. aureus, the main aim of this part of the project was 
to study the dynamics of intramammary challenge in cows and to determine if 
infusion with large numbers of different S. aureus strains induced clearance, 
alteration or persistence of the original subclinical mastitis. Another aim was to 
determine whether variations in the strain of S. aureus were evident when more 
than one colony of S. aureus per milk sample was examined employing recent 
molecular techniques such as Restriction Enzyme Fragmentation Pattern (REFP) 
Analysis and Repetitive Extragenic Palindromic Polymerase Chain Reaction 
(REP-PCR).
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In studying inflammation due to S aureus, the main aim of this part of the project 
was to investigate if SAA could be used as an indicator of inflammation in S. 
aureus mastitis and thus as a potential adjunct to future quality control 
programmes for dairy products. To facilitate this, the aim was to develop a 
monoclonal antibody raised specifically against bovine SAA by developing 
methods allowing improved purification of SAA.
37
Chapter 2
Infection in Bovine Staphylococcus aureus 
Mastitis
2.1 Introduction
One of the main aims of this part of the project was to investigate the effect of 
infusing S. aureus by the intramammary route into quarters already subclinically 
infected with S. aureus. It was considered necessary to infuse very large numbers of 
S. aureus bacteria into the quarters in order to provide sufficient challenge to the 
existing organisms colonising the tissue, and greater numbers of S. aureus were 
infused in this study than had been previously described in the literature.
To improve investigation of intramammary infection caused by S. aureus, it was 
decided to examine multiple colonies isolated from infected quarters and to use 
genetic fingerprinting to identify strain variation among cows and quarters.
Due to the time taken to perform the genetic fingerprinting using standard techniques, 
an attempt to develop a repetitive extragenic palindromic polymerase chain reaction 
(REP-PCR), which allowed more rapid identification of bovine S. aureus strains, was 
made.
2.2 Materials and Methods
2.2.1 Experimental Animals
To investigate the dynamics of intramammary infection with different strains of S. 
aureus, four adult Friesian cows with naturally occurring subclinical mastitis caused
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by S. aureus were studied. The cows were initially selected as having high ICSCC (> 
600,000/ml), and the infected quarters were subsequently identified by IQSCC (> 
400,000/ml), and S. aureus was isolated on routine bacteriology from them. Two 
cows, both from the same farm, were shown to be infected with the same strain on the 
basis of genomic DNA fingerprints (described in section 2.2.5.1) and the strain was 
designated strain A. Two other cows, both from a different farm, were shown to be 
infected by the same method with a different strain, designated strain B.
2.2.2 Intramammary Infusion with Staphylococcus aureus
Each cow described above was challenged with either 108 S. aureus per quarter in the 
case of the non-infected quarter, or 109 S. aureus in the case of infected quarters in a 
double crossover design, such that one cow from each farm was challenged with the 
indigenous strain and one cow from each farm challenged with the non-indigenous 
strain (Table 2.1). Throughout the trial all four quarters were used and given the 
prefixes LF, RF, LH and RH referring to the left fore, right fore, left hind and right 
hind quarters respectively.
Staphylococcus aureus cultures containing 1.25xl09 cells per ml in Brain Heart 
Infusion Broth (Oxoid, Basingstoke, Hampshire) were incubated overnight at 37°C 
and then centrifuged at 5670g for 10 minutes. The supernatant was decanted, the 
pellet was resuspended in 15ml Ringers solution and centrifugation and resuspension 
of the pellet was repeated. One and a half millilitres of cell suspension at 1.25xl010 
cells/ml was added to 20 ml Ringers solution and infused into infected quarters (i.e. a 
total of 109 bacteria), uninfected quarters had 20ml of a 1:10 dilution of the original 
cell suspension (i.e. a total of 108 bacteria) infused into them. Control quarters had 
only 20ml Ringers solution infused into them. The teats were prepared by washing 
and drying prior to thorough disinfection with surgical spirit. The first few draws of 
milk were discarded from each quarter immediately prior to intramammary infusion. 
The S. aureus cultures were infused using a 6FG dog urinary catheter inserted 
through the teat canal to which a 20ml syringe containing the bacterial culture was 
attached. Following infusion, the base of the quarter was massaged in an upward
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Cow
Number
Quarters infected 
prior to trial
Pre challenge 
strain isolated
Quarters 
challenged with 
1 1 10 * S. aureus
Quarters 
challenged with 
1 1 101 S. aureus
Challenge
strain
186 LF, RF, LH, RH A LF, RF, LH, RH B
125 LF, RF, LH A LF, LH A
520 RH B RH RF A
703 LF B LF LH B
Table 2.1: The double cross-over design for intramammary challenge with 
Staphylococcus aureus
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motion while holding the teat duct closed, to ensure thorough dispersion of the 
infused material into the gland cistern. None of the infusion was lost via the teat canal 
and all teats were then dipped in an iodophor teat dip. The cows were examined 
clinically at regular intervals for 48 hours after the infusion procedure and were 
milked twice daily by machine.
2.2.3 Milk Sample Collection
Individual quarter milk samples were collected by hand stripping on day -4 (pre­
challenge), and on days 3, 8 and 17 post-challenge.
2.2.4 Routine Bacterial Isolation from Milk Samples
Three millilitres of milk was mixed with 17ml of sterile distilled water and centrifuged 
at 4500g for 20 minutes. The cell pellet was resuspended in lOOpl of lauryl broth, 
from which 50pl was spread onto Columbia blood agar and mannitol salt agar plates 
which were incubated overnight at 37°C. After incubation, 15-20 individual S. aureus 
colonies, identified by colony morphology, were subcultured individually onto 
Columbia agar slopes and incubated overnight at 37°C. Inoculates Columbia agar 
slopes were then stored at 4°C.
Further strain characterisation was employed and used restriction enzyme 
fragmentation pattern (REFP) analysis.
2.2.5 Identification of Staphylococcus aureus Strains
2.2.5.1 Restriction Enzyme Fragmentation Pattern Analysis
Subculture of Staphylococcus aureus Strains. Ten millilitres of BHI broth (Oxoid) 
was inoculated aseptically from Columbia agar culture slopes and incubated overnight 
at 37°C. Columbia blood agar streak plates were also prepared and incubated to 
confirm the purity of the initial culture.
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Isolation of Genomic DNA
Purification of DNA. Purification of DNA was carried out over a period of two 
days. On day one of the purification procedure, overnight BHI broths were 
centrifuged at 4480g for 1 0  minutes and resuspended in 3ml Tris ethylene diamine 
tetra acetic acid sodium chloride buffer (TES) (50mM Tris-base, 50mM sodium 
chloride, 5mM disodium EDTA, (pH8.0)). The samples were then aliquoted into 3 
eppendorf tubes and microcentrifuged at 13,800g for 30 seconds before being 
resuspended in 200pl TES which contained 50mM sucrose to prevent cell lysis. 
Twenty microlitres of the endopeptidase lysostaphin (Sigma, lOOOunits/ml) which is 
specific for the pentaglycine bridge involved uniquely in the cell wall structure of S. 
aureus, and lOOjul lysozyme (Sigma, 40mg/ml) were added and mixed thoroughly 
before being incubated at 37°C for 30 minutes. After incubation 20% SDS (15pl) was 
added and mixed by inversion, fifty microlitres of Proteinase K (lOmg/ml) was also 
added before the sample was sheared through a 25 gauge needle to reduce the 
viscosity of the DNA and incubated for two hours at 37°C. One hundred microlitres 
of TEio (lOmM Tris base, lOmM disodium EDTA, (pH7.8)) was added to reduce the 
DNA concentration before the initial purification stage using phenol chloroform 
(500|lU). After mixing thoroughly, the samples were microcentrifuged at 13,800g for 
10 minutes and the aqueous layer was transferred to another eppendorf and 500pl of 
isopropanol was added. The samples were left at room temperature for 60 minutes to 
precipitate the DNA, followed by centrifugation at 13,800g for 10 minutes. The 
pellet was resuspended in 100pi TEio and triplicate tubes were pooled, lOOpl of 
ammonium acetate (7.5M, pH8.0) and 600pl of 95% ethanol were added and samples 
were stored at -20°C overnight, to precipitate the DNA.
On day two, further purification procedures were carried out. Samples were 
centrifuged at 13,800g for 10 minutes, resuspended in 300pl TEio and 20pl RNAase 
(Sigma, lOmg/ml) was added. After incubation at 37°C for 60 minutes, the 
phenol/chloroform, isopropanol and ethanol steps were repeated as above and the 
samples were again stored at - 2 0  overnight.
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Restriction Digestion of DNA. Restriction digestion was carried out on day three, 
the day immediately following the purification procedures. Samples were centrifuged 
at 13,800g for 10 minutes and resuspended in 60p.l TE (lOmM Tris base, ImM 
disodium EDTA (pH8.0)). Restriction digestion of each sample using restriction 
enzyme Hha I (Gibco Life Technologies Limited, Paisley) was carried out, with 
bacteriophage X DNA digested with Hha I, Kpn I and Pst I as controls. Restriction 
products mixed with loading buffer (25g sucrose, 60mg sodium acetate, lOOmg SDS 
and 50mg bromophenol blue in 100ml) were electrophoresed in a 0.8% agarose gel 
(2:1 dilution with TBE:distilled water, (Tris base 89mM, boric acid 89mM disodium 
EDTA 1.25mM, pH8.0-8.4)) at 25mA overnight and the gel was stained using 
ethidium bromide in TBE (0.5-1.Oug/ml ethidium bromide). Following removal of 
excess background staining by rinsing the gel in distilled water for approximately 15 
minutes, the gels were photographed on a transilluminator at 302nm using Polaroid 
film type 655.
Digitisation of Restriction Enzyme Fragmentation Pattern Results.
Interpretation of electrophoretic gels was a skill-intensive task. Digitisation of gel 
photographs was an objective yet flexible technique that allowed the accurate 
assessment of electrophoretic data. The statistical analysis was used to assess the 
accuracy of calibration data, and by limiting the percentage fragment size variation, 
accurate between-gel comparisons were made. Data was stored in numerical form 
(molecular weight of restriction fragments). The graphical output was used to present 
the data in a familiar format which allowed visual comparisons with the original gel 
photograph. Digitisation of REFP isolates allowed gel to gel-comparisons of S. 
aureus strains. Strains were analysed using a commercially available programme 
(Platt and Sullivan, 1992) with restriction digested X DNA using enzymes Kpn I and 
Pst I as calibration controls. Restriction fingerprints were compared using a 
coefficient of similarity calculated from the formula:
SD(%)= _2 m_ X 1 0 0
a+b
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where ‘m’ was the number of fragments common to two fingerprints and ‘a’ and ‘b’ 
were the total number of fragments generated from each fingerprint respectively after 
digestion by the same restriction enzyme (Dice, 1945).
The molecular weight of the control fragments was fitted to a robust modified 
hyperbola, from which the size of restriction fragments in adjacent tracks was 
estimated. Numerical values were stored for subsequent graphical output which was 
on a logarithmic scale, the experimental variation in fragment size did not exceed 5% 
(Plikaytis eta l., 1986).
2.2.5.2 Repetitive Extragenic Palindromic Polymerase Chain Reaction
The repetitive extragenic palindromic polymerase chain reaction (REP-PCR) was used 
to obtain a rapid method for the identification of strain diversity in the bovine 
staphylococci. Genomic DNA was prepared by isolation of genomic DNA as 
described previously in section 2.2.5.1 following the purification stages carried out on 
day one and day two during REFP analysis. Fifty nanograms of genomic DNA was 
amplified in a total volume of 50pl containing 50pmols of primer REP 1R (5’ 111 
NCgNCgNCATCNggC3’, R and D Systems Europe limited, Abingdon) and REP 2 
Dt (5’ NCgNCTTATCNggCCTAC3’, R and D Systems), 250pM of dATP, dTTP, 
dCTP, and dGTP (Pharmacia, St. Albans, Herts.), lOmM Tris-HCL, 1.5mmol/l MgCl, 
50mM/l KCL, 0.1 mg/ml gelatin and 2.5 units of Dynazyme (Flowgen, Lichfield, 
Staffordshire). DNA samples were subjected to an initial denaturation of 94°C for 7 
minutes, followed by 32 cycles of 94°C for 1 minute, 37°C for 1 minute, 72°C for 8  
minutes followed by a final extension of 72°C for 16 minutes using a Perkin Elmer 
480 Thermocycler (Perkin Elmer, Warrington). Amplification efficiency was 
determined by agarose electrophoresis using a 1 .2 % agarose gel and viewed as 
described for REFP analysis. Initially, strain A, strain B and strain A* were used for 
the optimisation of the protocol, which involved reducing the primer annealing 
temperature by 3°C to 37°C, varying the target DNA concentration, primer and 
magnesium chloride concentrations.
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Restriction Digestion of REP-PCR Products. Restriction digestion of the REP- 
PCR products was carried out to determine if any further strain pattern variation 
could be identified using this method. The digestion enzymes used were Rsa I, Alu I, 
Stu I, Hind III, Pst I, Hae III, Eco RI, Bam HI, Hpa I and Kpn I. Each digest 
contained lOpl of PCR product, 2pi of appropriate enzyme buffer, 3 pi of enzyme and 
distilled water to give a total volume of 20pl. The samples were incubated overnight 
at 37°C in a water bath. Following incubation the samples were electrophoresed on a 
1 .2 % agarose gel, containing ethidium bromide.
2.3 Results
2.3.1 Infection in Staphylococcus aureus Mastitis
2.3.1.1 Isolation of Staphylococcus aureus from Milk Samples
Routine bacteriological analysis was carried out in the commercial laboratory at the 
Scottish Agricultural College, Auchincruive. Routine bacteriological analysis 
identified bacteria from each quarter of each cow on each sampling day. Quarters 
were recorded as either S. aureus positive or S. aureus negative and the presence of 
other bacterial species was also recorded. Initial identification of S. aureus was based 
on colony morphology and a positive coagulase test. The distribution of positive 
samples is shown in Table 2.2. Throughout the study, uninfected quarters were 
designated as control quarters and were analysed to confirm that cross-contamination 
had not occurred during the infusion procedure and subsequent sampling.
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Cow Number Sample Day S. aureus 
Positive
S. aureus 
Negative
125 - 1 RF, LF, LH RH
125 3 RF, LF, LH RH
125 8 RF, LF, LH RH
125 17 LF, LH RF, RH
186 - 1 RF, LF, RH, LH
186 3 RF, LF, RH, LH
186 8 RF, LF, RH, LH
186 17 RF, LF, RH, LH
520 - 1 RH RF, LF, LH
520 3 RF, RH LF, LH
520 8 RH RF, LF, LH
520 17 RF, RH LF, LH
703 0 LF RF, RH, LH
703 3 LF, LH RF, RH
703 8 LH RF, RH, LH
703 17 RF, LF, RH, LH
Table 2 .2 : Routine bacteriological results from all quarters from cows 125, 186 and 
520 on four sampling days i.e. day -1 (pre-challenge) and days 3, 8  and 17 post­
challenge. Routine bacteriological screening from all quarters from cow 703 on four 
sampling days i.e. days 0 (pre-challenge), 3, 8 , and 17 post-challenge.
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2.3.1.2 Differentiation of Staphylococcus aureus Strains
Restriction Enzyme Fragmentation Pattern Analysis and Digitisation of Results.
Bacterial isolates were fingerprinted and analysed by REFP from all four quarters of 
each cow on four occasions during the study i.e. day -4 (pre-challenge) and days 3, 8 , 
and 17 post-challenge. A total of 400 cultures were studied by REFP analysis. The 
four cows studied were challenged by the intramammary route as shown in table 2 .1 .
Following digestion of bacterial isolates with restriction digest Hha I, a strain with 25 
fragments ranging from 2.92 kilobases to 9.59 kilobases in size was identified and was 
designated strain A (figure 2.1, Lanes 6-14). Digitisation of the REFP results is 
shown in figure 2.2, Lanes 6-14. A molecular variant of strain A (A*) was also 
recognised; 25 fragments were evident following digestion with restriction digest Hha. 
I. Twenty-four of the 25 fragments matched those of strain A (figure 2.1, Lanes 1-5). 
Digitisation of the REFP results is shown in figure 2.2, Lanes 1-5. The only 
difference between strain A and A* was in the largest fragment, with strain A 
fragment size being 9.59 kb and strain A* fragment size being 9.32 kb.
Following digestion of bacterial isolates with restriction digest Hha. I, a strain with 30 
fragments ranging in size from 2.92-9.59 kb was identified and was designated strain 
B (figure 2.3, Lanes 3, 4, 6 , 8-15). Digitisation of the REFP results is shown in figure 
2.4, Lanes 3, 4, 6 , 8-15.
Seven genetically unrelated strains were recognised by REFP analysis as strains other 
than strain A, strain A* or strain B and were designated strains Ri to R7 (figure 2.7, 
Lanes 5-11). As an example of an unrelated strain, Ri, is shown in lane 8  in figure 2.5 
and following digitisation in figure 2.6. The REFP results from additional strains 
were digitised (figure 2.7, lanes 5-11) and the total number of fragments identified and 
the size of each determined. These additional strains ranged in fragment number from 
20-36 fragments with sizes of 2.86-15.88 kb and were isolated both pre and post­
challenge (Table 2.3).
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1 2 3 4 5  6 7 8  9 10 11 1 2 1 3 14 15 16 17
Figure 2.1: REFP of bacterial isolates from cow 186 on day -4 (pre-challenge) from 
RH and LH quarters; ethidium bromide (0.5-1.0 fig/ml) stained 0.8% agarose gel. 
DNA was digested using restriction endonuclease Hha I. Lanes 1-5 show isolates 
from RH identified as A*. Lanes 6-14 show isolates from LH identified as strain A. 
Bacteriophage X DNA controls were digested with Hha I, Kpn I and Pst I and are 
shown in Lanes 15, 16 and 17 respectively.
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Figure 2.2: Graphical output of digitised image from figure 2.2. Lanes 1 - 5  show 
isolates from RH identified as A*. Lanes 6-14 show isolates from LH identified as 
strain A. Bacteriophage X DNA controls were digested with Hha I, Kpn I and Pst I. 
Lanes 15 and 16 show Kpn I and Pst I respectively.
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Figure 2.3: REFP of bacterial isolates from cow 520 on day 17 post-challenge from RF 
and RH quarters after digestion with Hha I; ethidium bromide (0.5-1.0pg/ml) stained 
0.8% agarose gel electrophoresis. Lanes 1-7 show isolates from the LH quarter. 
Lanes 1, 2, 5 and 7 show strain A whereas lanes 3, 4 and 6 show strain B. Lanes 8-15 
show isolates from the RH quarter and were strain B. Bacteriophage X DNA controls 
were digested with Kpn I, Pst I and Hha I and are shown in lanes 16-18 respectively.
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Figure 2.4: Graphical output of digitised image from figure 2.3. Lanes 1-7 show 
isolates from the LH quarter. Lanes 1, 2, 5 and 7 show strain A whereas lanes 3, 4 and 
6  show strain B. Bacteriophage X DNA controls were digested with Kpn I, Pst I and 
Hha I. Lanes 15 and 16 show Kpn I and Pst I respectively.
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Figure 2.5: REFP of bacterial isolates from cow 186 on days 3 and 17 post-challenge 
from RH quarter; ethidium bromide (0.5-1.0pg/ml) stained 0.8% agarose gel 
electrophoresis. Samples were digested using restriction endonuclease Hha I. 
Bacteriophage X DNA controls were digested with Kpn I, Pst I and Hha I and are 
shown in lanes 1, 2 and 3 respectively. Lanes 4-10 show isolates from RH quarter on 
day 17 post-challenge. Lanes 4, 6, 9 and 10 show strain A*, whereas lanes 5 and 7 
show strain A. Lane 8 shows strain Ri. Lanes 11-18 show isolates from RH day 3 
post-challenge and were identified as strain A*.
w1 2  3 4  5 6  7 8  9 10 11 12 13 14 15 16 17
Figure 2.6: Graphical output of digitised image from figure 2.5. Bacteriophage X 
DNA controls were digested with Kpn I, Pst I and Hha I. Lanes 1 and 2 show Pst I 
and Kpn I respectively. Lanes 3-9 show isolates from RH quarter on day 17 post­
challenge. Lanes 3, 5, 8  and 9 show strain A*, whereas lanes 4 and 6  show strain A. 
Lane 7 shows strain Ri. Lanes 10-17 show isolates from RH day 3 post-challenge and 
were identified as strain A*.
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Figure 2.7: Graphical output of digitised image of REFPs after Hha I digestion of 
genomic DNA. Strain A (Lane 1), strain A* (Lane 2) and Strain B (Lane 3). 
Additional distinct isolates R1-R7 are shown in lanes 5-11 respectively.
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Coefficient of Similarity between Strains. The similarity coefficient between strain 
A and strain A* was 96% (24 of the 25 fragments matching). A similarity coefficient 
of 83.6% was shown between strain A and strain B with 23 of the 30 fragments 
matching. Strain A* and strain B also had a percentage similarity coefficient of 
83.6% with 23 of the 30 fragments matching. Strain A and strain A* showed 
between 48.9-73.7% similarity to strains Ri to R7, whereas strain B had between 
52.0-83.9% similarity to strains Ri to R7 (Tables 2.4 and 2.5).
2.3.1.3 Discrimination Between Strains of Bovine Staphylococcus aureus by 
Polymerase Chain Reaction
REP-PCR amplification using REP-1 and REP-2 primers on strain A genomic DNA 
generated two products of approximately 1,300 base pairs and 2,000 base pairs. The 
same method using strain B genomic DNA as the template, generated products of 
1,100 base pairs and 2,000 base pairs (figure 2.8). The two strains were, therefore, 
distinguished by this method. However, using this method, no difference in the size 
amplification of products was observed between strain A and strain A* and identical 
banding patterns were seen (figure 2 .8 ).
Under the same REP-PCR conditions and cycling parameters, genomic DNA from 
strains Ri to R7 gave entirely different banding patterns to strains A, B or strain A* 
(Figure 2.9).
Restriction Digestion of REP-PCR amplification products. Restriction 
endonuclease digestion was carried out to identify any variation between REFP 
fingerprinted genomic DNA from strain A and strain A*. The digestion enzymes Rsa 
I, Alu I, Hind III, Pst I, Hae III, Eco RI, Bam HI and Kpn I all gave no variation in 
amplification product between strain A and strain A*. Only restriction endonuclease 
Stu I gave a slight variation in amplification products between strain A and strain A* 
(Figure 2.10, Lanes 6  and 7). The variation was the presence of an additional band in 
strain A in lane 6 . Digestion enzymes Rsa I, Alu I, Hind III, Pst I and Hae III are 
shown as examples of the absence of variation in restriction digestion of REP-PCR 
amplification products in figure 2.10 (lanes 2-5, 8-13).
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1 2  3 4
Figure 2.8: PCR amplification products obtained using REP-1 and REP-2 primers after 
agarose electrophoresis using a 1.2% agarose gel. Lane 1 shows 100 base pair ladder. 
Lane 2 shows strain A PCR amplification products of 1,300 and 2,000 base pairs. 
Lane 3 shows strain A* amplification products of 1,300 and 2,000 base pairs. Lane 4 
shows strain B amplification products of 1,100 and 2,000 base pairs.
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Figure 2.9: PCR amplification products obtained using REP-1 and REP-2 primers after 
agarose electrophoresis using a 1.2% agarose gel. Lanes 1-5 show amplification 
products obtained from additional isolates Ri to R7, previously identified by REFP 
analysis.
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Figure 2.10:Restriction digestion of REP-PCR amplification products after agarose 
electrophoresis (1.2% agarose). Lane 1 shows 100 base pair ladder. Lane 2 shows 
strain A digested with Rsa I. Lane 3 shows strain A* digested with Rsa I. Lane 4 
shows strain A digested with Alu I. Lane 5 shows strain A* digested with Alu I. Lane 
6 shows strain A digested with Stu I. Lane 7 shows strain A* digested with Stu I. 
Lane 8 shows strain A digested with Hind III. Lane 9 shows strain A* digested with 
Hind III. Lane 10 shows strain A digested with Pst I. Lane 11 shows strain A* 
digested with Pst I. Lane 12 shows strain A digested with Hae III. Lane 13 shows 
strain A* digested with Hae III.
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2.3.2 Dynamics of Intramammary Infection Following Experimental 
Challenge with Staphylococcus aureus
2.3.2.1 Cows Challenged with the Indigenous Strain of Staphylococcus aureus
Multiple colonies from each S. aureus positive quarter were analysed by REFP on 
each sampling day (tables 2.6 and 2.7)
Cow 125. Cow 125 was identified originally as naturally infected with strain A in the 
LF, LH and RF quarters and was challenged with the indigenous strain A into the LF 
and LH quarters. In the LH on day -4 (pre-infusion) isolates R5 and R2 were 
identified although the LH quarter had been identified as having been naturally 
infected with strain A on initial screening prior to this sample date. The challenge 
strain A was infused into the LF and LH quarters and strain A was isolated in these 
two quarters on subsequent sampling days. Strain A was identified in the LH quarter 
on day 3 post-challenge indicating that it has successfully colonised this quarter, 
remaining until day 17 post-challenge. It is possible that infusion of large numbers of 
strain A into the LH quarter may have replaced the R 5 and R2 strains as the persisting 
organisms. Alternatively, failure to isolate strains R5 and R2 may have been simply 
due to a dilution effect where the presence of large numbers of strain A made random 
sampling of other strains less likely. The RF quarter which was naturally infected with 
strain A and did not receive any bacterial infusion was still infected with strain A at 
the end of the experiment. In the LF and RF quarters on day 17 post-challenge, while 
strain A predominated, unrelated strains R2 (LF) and R5 (RF) were also isolated as 
single colonies.
Cow 703. The LF quarter of cow 703 was naturally infected with strain B and she 
was subsequently challenged with strain B in the LF and LH quarters. Strain B was 
isolated on day 3 post-challenge in the LF quarter. On day 8 , strains other than strain 
A or B were isolated in the LF quarter and were designated strains R3, R4, R6 and R7. 
Strain B was isolated as a homologous population on day 3 and day 8  from the LH 
quarter (Table 2.7). On day nine post-challenge cow 703 suddenly developed signs of
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Staphylococcus aureus strains isolated from each quarter of cow 125
SAMPLE DAY LF
Infected A 
Challenged A
RF
Infected A
LH
Infected A 
Challenged A
RH
Control
Day -4 (pre­
challenge)
AAAAAAAAA AAAAAAAAA
A
r5
r2
NT
(9) (10) (2)
Day 3 (post 
challenge)
NT NT
AAAAAAAAA
A
(10)
NT
Day 8 (post 
challenge)
NT NT NT NT
Day 17 (post 
challenge)
AAAAAAA
r2
AAAAAAAAA
Rs
AAAAAAAAA
NT
(8)
(10) (9)
Table 2.6: Staphylococcus aureus strains identified by REFP analysis, from four 
quarters on four sampling days i.e. day -4 (pre-challenge) and days 3, 8, and 17 post­
challenge. Total numbers of colonies subcultured are shown in brackets. A = Strain A, 
B = Strain B, A* = Variant Strain A. R2 and R5 = additional isolate. NT = not 
analysed. LF, LH, RF, and RH denotes the left fore, left hind, right fore and right 
hind quarters respectively.
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Staphylococcus aureus stra in s  iso la ted  fro m  ea ch  q u a r te r  o f  co w  7 0 3
SAMPLE DAY LF
Infected B 
Challenged B
RF
Control
LH
Challenged B
RH
Control
Day -4 (pre­
challenge)
BBBBBBBBB
(9)
NT NT NT
Day 3 (post 
challenge)
BBB
(3)
NT
BBBBBBBBB
(9)
NT
Day 8 (post 
challenge)
R3R3
R4
R6
R7R7R7R7R7
(8 )
NT
BBBBBBBBBB
( 1 0 )
NT
Day 17 (post 
challenge
NT NT NT NT
Table 2.7: Staphylococcus aureus strains identified by REFP analysis, from four 
quarters on four sampling days i.e. day -4 (pre-challenge) and days 3, 8, and 12 post­
challenge. Total number of colonies sub-cultured are shown in brackets. A = strain A, 
B = strain B. R = additional strain. NT= not analysed. LF, RF, LH and RH denotes 
the left fore, right fore, left hind and right hind quarters respectively.
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severe mastitis including reddening and swelling of the quarters. The cow was 
pyrexic and anorexic. Under Home Office Regulations the cow was treated with 
flunixin meglumine (Finadyne, Schering-Plough Limited), a non-steroidal anti­
inflammatory and an antibiotic amoxycillin/clavulanic acid (Synulox, Pfizer Limited). 
No samples were therefore obtained from day 17 post-challenge for cow 703 as 
alteration in milk composition prevented the isolation of bacteria for subculture and 
REFP analysis.
2.3.2.2 Cows Challenged with the Non-Indigenous Strain of Staphylococcus 
aureus
Multiple colonies from each S. aureus positive quarter were analysed by REFP on 
each sampling day (table 2.8 and 2.9)
Cow 186. All four quarters of this cow were thought to be naturally infected with 
strain A on initial screening, however, while the other three quarters were shown to 
be infected with strain A, the RH quarter was shown to be naturally infected with 
strain A*. Following challenge of all four quarters with the non-indigenous strain B, 
REFP analysis showed that strain B was not isolated from any quarter post-challenge. 
Strain A was isolated from the LF, RF and LH in all the sampling days post-challenge 
(days 3, 8 and 17). Strain A* was isolated from the RH quarter on day -4 (pre­
challenge), and on day 3 (post-challenge) as a homogeneous population. However, 
on day 17 post-challenge the RH quarter contained a mixed population of strain A, 
strain A* and one other isolate which was not strain A, strain A*, R2 or R5 (identified 
in cow 125 previously) and was designated strain Ri (Table 2.8).
Cow 520. Cow 520 was naturally infected with strain B in a single quarter, the RH, 
and was challenged with strain A in both the RH and RF quarters. Strain B was 
confirmed as the only isolate from the RH quarter pre-challenge (day -4). Strain A 
was identified as a homogenous population on all isolates tested on day 3 post­
challenge from the RH quarter, but by day 8 post-challenge, strain B was again 
identified in all isolates tested from the RH quarter and again on day 17 post-
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Staphylococcus aureus strains isolated from each quarter o f cow 186
SAMPLE DAY LF
Infected A 
Challenged B
RF
Infected A 
Challenged B
LH
Infected A 
Challenged B
RH
Infected A 
Challenged B
Day -4 (pre­
challenge)
AAAAAAAA
(8)
AAAAAAAAA
AAA
(12)
AAAAAAAAA
(9)
A*A*A*A*A*
A*A*A*A*A*
(10)
Day 3 (post 
challenge)
AAAAAAAAA
AAAAAA
(14)
AAAAAAAAA
AAAAAAAA
(17)
AAAAAAAAA
(9)
A*A*A*A*A*
A*A*A*A*A*
A*A*A*A*A*
A*A*
(17)
Day 8 (post 
challenge)
AAAAAAAAA
AAAAAAAA
(17)
NT NT NT
Day 17 (post 
challenge)
AAAAAAAAA
AAAAAAAA
(17)
AAAAAAA
(7)
NT
AA
A*A*A*A*
Ri
(7)
Table 2.8: Staphylococcus aureus strains identified by REFP analysis, from four 
quarters on four sampling days i.e. day -4 (pre-challenge and days 3, 8, and 17 post­
challenge. Total numbers of colonies sub-cultured are shown in brackets. A = strain 
A, B = strain B and A* = variant strain A. R = additional isolates. NT = not analysed. 
LF, RF, LH and RH denotes the left fore, right fore, left hind and right hind quarters 
respectively.
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Staphylococcus aureus strains isolated from each quarter of cow 520
SAMPLE DAY LF
Control
RF
Challenged A
LH
Control
RH
Infected B 
Challenged A
Day -4 (pre­
challenge)
NT NT NT
BBBBBBBBBB
BBBBBBBBBB
(20)
Day 3 (post 
challenge)
NT
AAA
(3)
NT
AAAAAAAAA
AAAAA
(14)
Day 8 (post 
challenge)
NT
AAAAAAAAA
(9)
NT
BBB
(3)
Day 17 (post 
challenge)
NT
AAAA
BBB
(7)
NT
BBBBBBBBBB
B
(11)
Table 2.9: Staphylococcus aureus strains identified after REFP analysis, from four 
quarters on four sampling days i.e. day -4 (pre-challenge) and days 3, 8, and 17 post­
challenge. Total numbers of colonies sub-cultured are shown in brackets. A = strain 
A, B = strain B. NT = not analysed. LF, RF, LH and RH denotes the left fore, right 
fore, left hind and right hind quarters respectively.
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challenge. In the RF quarter, strain A was isolated on days 3 and 8 post-challenge. 
This result indicates that challenge with strain A resulted in persistence of this strain in 
this quarter for the duration of the study. However by day 17 post-challenge, both 
strain A and strain B were isolated from the RF quarter (table 2.9).
2.4 Discussion
The accurate determination of intramammary infection status is essential in 
conducting mastitis research and herd control (Sears et al., 1990). There are a variety 
of diagnostic tests available for identifying mastitis and detecting infection levels in 
dairy herds. Methods for diagnosis have classically been divided into two major 
categories 1.) the detection of alteration in milk as a consequence of pathophysiologic 
changes due to an inflammatory response, 2.) the direct detection of microorganisms 
in milk by culture (Sears and Heider, 1981). However, the continued high incidence 
of chronic mastitis indicates that current control measures are sub-optimal and that 
the development of effective methods will require a more precise understanding of 
both the epidemiology of chronic mastitis within and between herds, and also a clearer 
view of the host-bacteria relationship within an immunological framework.
In recent years, new bacteriological and epidemiological techniques have become 
available to study patterns of infection in bovine mastitis (Lam, 1996). With modem 
techniques such as DNA fingerprinting and amplification of DNA by PCR, 
information for both diagnosis and epidemiology of intramammary infections may be 
provided quickly and reliably to allow detailed studies of natural bovine mastitis 
infections (Matthews et at, 1994).
The present study followed the development of a strategic approach to REFP analysis 
based on restriction enzymes that recognise a 4-base rather than 6-base cleavage site 
in DNA. This technique provides a large amount of information, amenable to 
computer analysis and adaptable to a wide range of micro-organisms (Platt et al,
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1994). Firstly, from case control studies of human S. aureus infection, variation in 1- 
3 restriction fragments constituted clonal variation and that unrelated strains differed 
in > 7 fragments. Secondly, in studies of bovine S. aureus in Scottish herds there was 
evidence of clonal variation within individual herds. This observation was based on 
the analysis of a single colony from each sample tested as in the standard diagnostic 
procedure. This raised the important question of whether strain variation reflected the 
choice of colony for study, genotypic diversification within the herd, or whether 
individual cows harboured one or more variants. Furthermore, the chronicity of 
bovine S. aureus mastitis raises the possibility that a cow may acquire different strains 
of S. aureus at different times that remain co-resident within the udder and would 
have consequences for the host-parasite relationship immunologically. Thus one of 
the initial aims of this study was to determine whether strain variation was evident 
within an individual quarter or cow and to what extent when multiple colonies were 
analysed from the same milk sample. Another aim of this project was to study the 
dynamics of intramammary challenge with S. aureus in four cows with subclinical S. 
aureus mastitis in one or more quarters. A double cross-over design was employed 
such that one cow from each source was challenged with the indigenous strain and the 
other cow was challenged with the non-indigenous strain. This approach allowed us 
to determine if the indigenous strain was displaced by the non-indigenous strain, or 
whether superinfection with the indigenous strain altered or had no effect on the 
original infection status of that quarter. This study also used a novel approach for 
intramammary infusion with S. aureus. Two concentrations of S. aureus were used 
for intramammary challenge depending on the original infection status of the quarter: 
l.OxlO8 c.f.u/ml. were infused into non-infected quarters, whereas l.OxlO9 c.f.u/ml. 
were infused into infected quarters. The high concentration of bacteria infused into 
the mammary gland in this study was in contrast to a study by Sears et a l (1990), 
which observed the shedding pattern of S. aureus from bovine intramammary 
infections. In that study a challenge dose which ranged from 20-2,000 c.f.u/ml was 
infused by the intramammary route (Sears et al, 1990). However in the cited study 
the strain used was a particularly virulent S. aureus and of 21 previously uninfected 
glands challenged with S. aureus, 19 became infected. In the present study, the 
strains selected were isolated from cows with subclinical mastitis which are 
presumably less virulent than strains involved in clinical mastitis. It was considered
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that it was necessary to infuse large numbers of bacteria into an infected gland in this 
study in order to provide a significant challenge to the existing organisms.
Although bacteriological culture of milk is commonly utilised for diagnosis of 
intramammary infection (Sears et al., 1991), the milk collection technique, 
transportation and culture methodology should be taken into account when 
interpreting the microbial growth from a milk sample. Routine bacteriological 
screening generally involves single colony analysis. Many authors including Aarestrup 
et al. (1995(a)), Lam et al. (1996) and Birgersson etal. (1992) based their findings on 
the single colony analysis of an ‘apparently pure culture’. These apparently pure 
cultures were identified by basic methods such as colony morphology, Gram-stain, 
coagulase, catalase test, lack of oxidase activity, antibiotic sensitivity and antibiogram 
typing. These methods of identification may however fail to identify all strains of S. 
aureus especially if they occur at low frequency.
In the present study, routine bacteriological investigation in the commercial laboratory 
resulted in S. aureus being isolated from the challenged quarters in three of the four 
cows (125, 186 and 520) whether the quarters were previously infected or uninfected 
on the majority of occasions. However on three separate occasions (cow 125, day 
17, RF; cow 520, day 8 , RF; cow 703, day 8 , LF) bacteriological screening identified 
these individual quarters as S. aureus negative. These quarters were subsequently 
identified as S. aureus positive following REFP analysis and strain identification in the 
research laboratory, which may reflect differences in primary isolation techniques 
between the two laboratories. The failure to identify several infected quarters as S. 
aureus positive following routine bacteriological screening confirms that routine 
bacteriology is not 1 0 0 % effective in the identification of intramammary infection. 
The study by Sears et a l (1990) concluded that routine bacteriological screening from 
a single quarter milk sample was only 75% sensitive in the diagnosis of intramammary
infection caused by S. aureus, thus 25% of infected cows may have a ‘false’ negative 
single culture result. Routine bacteriological investigation did not result in S. aureus 
isolation from both the challenged quarters (LF, LH) of the fourth cow (703) on all
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the sampling dates. Cow 703 was naturally infected in the LF quarter with strain B 
and subsequently challenged in this quarter with strain B. The LH quarter which was 
originally uninfected was also challenged with strain B. S. aureus was not isolated in 
any quarters from day 10 post-challenge although it was detected on days 3 (LF and 
LH quarters) and 8  post-challenge (LH only). Failure to isolate S. aureus from this 
cow from day 1 0  post-challenge onwards was probably the result of systemic 
antibiotic therapy with amoxycillin/clavulanic acid (Synulox) which was administered 
on day 9 post-challenge. Failure to isolate the bacteria following therapy probably 
indicates that the antibiotic was either effective in killing the S. aureus in the 
mammary gland or reduced the shedding of the organism into the milk for the period 
of the study.
Restriction enzyme fragmentation pattern analysis was used to determine strain 
variation of S. aureus genotypically. REFP was shown to discriminate between both 
similar and unrelated strains of S. aureus in this study. REFP allowed discrimination 
of two similar strains of S. aureus, strain A and strain A* in the cows. Strain A and 
strain A* had almost identical REFP patterns which differed by a single restriction 
fragment and were clearly clonal variants. The largest fragment of strain A* was 
slightly smaller (9.32 kilobases) than strain A (9.59 kilobases). The two main strains 
involved in this study, strain A and strain B, were unrelated. Following digestion of 
strain A, 25 fragments ranging from 2.92-9.59 kilobases in size were identified. Strain 
B had 30 fragments ranging in size from 2.92-9.59 kilobases. Seven additional 
unrelated strains were identified following REFP and designated strains Ri to R7. 
These additional strains ranged in fragment number from 20-36 with fragment sizes 
ranging from 2.86-15.88 kilobases. These findings were similar to those of Jayarao 
et al. (1991) who used REFP analysis to identify and differentiate closely related and 
unrelated strains of S. uberis isolated from bovine mammary secretions. Jayarao et al. 
(1991) analysed 42 strains of S. uberis from 17 cows throughout lactation and
identified 17 REF patterns. Analysis of these isolates by bacteriocin-like inhibitory 
substance (BLIS) patterns resulted in only 12 patterns being identified (Jayarao et al., 
1991). Hill and Leigh (1989) also used DNA fingerprinting to analyse S. uberis 
isolates and concluded that DNA fingerprinting was a simple and reproducible typing
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system based on the restriction fragment size of chromosomal DNA. They reported 
that the endonuclease Hind III was the most successful in the differentiation of S. 
uberis isolates. Matthews et a l (1992) used DNA REFP to analyse 51 
staphylococcal isolates from the mammary secretions of cows with subclinical mastitis 
and identified 7 S. aureus isolates with 2 distinct REF patterns. Isolates were 
evaluated using a computer integrated scanning laser densitometer which allowed the 
determination of fragment sizes. Differences in REF patterns were identified as 
variation in the number and size of fragments, with each REFP designated as a distinct 
pattern. Visual comparison of REFP photographs was also undertaken to verify 
results obtained by densitometric scanning. In the present study, strain A* was shown 
to be 96% similar to strain A after digitisation and 24 of the 25 fragments matched. 
Strain A and strain B showed 83.6% similarity and 23 of the 30 fragments matched. 
Matthews et al. (1992), Hill and Leigh (1989) and Jarayao et a l (1991) all used 
densitometric scans and graphic displays of restriction patterns in the analysis of 
results. Forty-two REF patterns were compared to each other by Jarayao et a l 
(1991) and this resulted in the identification of related and unrelated strains. These 
methods allowed comparison of strains by fragment size and fragment numbers, 
distinguishing similar and unrelated strains on this basis. The accurate comparison of 
different strains over a period of time could also be accomplished using this method of 
data retrieval and storage.
In this study, a cow with two almost identical strains of S. aureus, which differed by 
only one fragment following REFP analysis was recognised. Cow 186 was thought to 
be naturally infected with strain A in all four quarters on initial screening. On the 
basis of REFP analysis, the RH quarter was shown to be naturally infected with strain
A*. It seems likely that the strain A* was derived originally from strain A. Multiple 
colony analysis in this project showed that, on several occasions, more than one strain 
of S. aureus was isolated from a single quarter. Both related and unrelated strains of 
S. aureus were isolated from the same quarter on the same sampling day in an 
individual animal. One example of the isolation of two closely related strains from the
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same quarter on the same sampling day was the identification of strain A and strain 
A* in the RH quarter of cow 186 on day 17 post-challenge. The identification of 
unrelated strains of S. aureus from the same quarter on the same sampling day 
occurred in other cows in the study. The RF quarter of cow 520 on day 17 post­
challenge was shown to contain a ‘mixed’ population of strain A and strain B, the two 
main strains in this study, following REFP analysis. Another example of the 
identification of two unrelated strains from the same quarter on the same sampling day 
was in the LF quarter of cow 125 on day 17 post-challenge when strain A and strain 
R2 and in the RF quarter of the same cow on the same day post-challenge when strain 
A and R5 were identified following REFP analysis. These findings can be compared 
to a study by Jayarao et a l (1991) which analysed the genotypic and phenotypic 
variation of S. uberis isolates from bovine mammary secretions. Jayarao et a l (1991) 
concluded that related strains of S. uberis were isolated in different quarters of the 
same gland on the same sample day, isolated in the same quarter of the same gland 
over a period of time and also that related strains were detected in different quarter of 
the same gland on the same day. Unrelated strains were identified by Jayarao et a l 
(1991) from different quarters of the same gland on the same day and also from the 
same quarter of the gland over a period of time. Therefore in the present study, 
multiple colony analysis by REFP resulted in a more accurate identification of S. 
aureus strain diversity within a quarter than single colony analysis by routine 
bacteriological methods. Multiple colony analysis is, therefore, a useful technique in 
studying bovine mastitis caused by S. aureus.
DNA fingerprinting is another technique used in studying the epidemiology of clinical 
and subclinical mastitis (Lipman et al, 1995; 1996). By comparing isolates between 
and within herds, it is possible to draw conclusions about the source and spread of
bacteria. For example, a study by Lam et a l (1996) showed that different E. coli 
genotypes were identified from different quarters, suggesting that E. coli is an 
environmental pathogen and does not spread from quarter to quarter. In contrast, 
Lam et a l (1996) showed that a limited number of S. aureus genotypes (11) were 
identified among 63 S. aureus isolates from five herds, supporting the theory that 
contagious pathogens transfer between cows and quarters within a herd. S. aureus
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strain identification using the DNA RAPD assay also showed that the majority of 
recurrent cases of S. aureus mastitis were the same genotype, suggesting either 
intermittent shedding from a chronically infected quarter or repeated infection with 
the same pathogen (Lam et al, 1996). Results from the present study, indicate the 
existence of several strains of S. aureus identified from the four cows studied. REFP 
analysis identified eight additional strains other than the two main strains in the study, 
strain A and strain B, and demonstrated that mixed infection occurs and that the 
investigation of a single colony may not provide a complete understanding of infection 
patterns.
One disadvantage of REFP analysis is the lengthy process, extending to 2-3 days, 
required to obtain bacterial DNA of sufficient purity for subsequent digestion with 
restriction endonucleases. This isolation method is similar to the technique used by 
Matthews et a l (1992) who used restriction endonuclease fingerprinting of 
staphylococcal species of bovine origin. Other methods such as ribotyping performed 
by Aarestrup et al. (1995(c)) and MLEE by Kapur et a l (1995) which have been used 
in the identification of staphylococci are also lengthy processes. In this study REP- 
PCR was developed as a rapid method for the identification of strain diversity in the 
bovine S. aureus. REP-PCR was shown to clearly distinguish unrelated strains of S. 
aureus whereas closely related strains were not distinguished using REP-PCR. This 
technique was shown to discriminate between strain A, and strain B and also among 
strains Ri - R7. REP-PCR however, did not discriminate between strain A and strain 
A* and was therefore less sensitive than REFP.
Similar techniques have been employed to study variation in other mastitis pathogens. 
Jayarao et al. (1992) compared REF and DNA amplification fingerprinting (DAF) in 
the subtyping of S. uberis in cattle. REF grouped 22 strains into 12 distinct patterns 
whereas DAF grouped them into 15 distinct patterns, indicating that DAF is an 
effective typing method and more discriminatory then REF in the typing of S. uberis 
strains. Jayarao et al. (1991) suggested that possible variation between typing 
methods (REF and BLIS) could be due to the recent identification of S. parauberis
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which is biochemically, physiologically and serologically identical to S. uberis, with 
only a slight genotypic variation differentiating the two strains.
Lam etal. (1996), Lipman etal. (1996) and Matthews et al. (1994) all used variations 
of the PCR to differentiate strains of S. aureus isolated from the mammary glands of 
cows. Lam et al. (1996) used ERIC primers for differentiation of E. coli and an 
arbitrary primer for S. aureus strain differentiation (RAPD assay). Lipman et al. 
(1996) used RAPD, ERIC1R and ERIC primers in the differentiation of S. aureus 
isolates, identifying and subtyping 71 S. aureus strains. The different primer sets used 
by Lipman et al. (1996) gave no variation in the ability to differentiate between strains 
under the conditions specified. PCR was shown to be a preferable method to 
biotyping as it is a much more specific typing method van Belkum et al. (1993), 
Lipman et al. (1995) and Wang et al. (1993). Matthews et al. (1994) used a synthetic 
oligonucleotide primer which provided a high degree of resolution in the 
differentiation of S. aureus strains with seventy-five S. aureus isolates grouped into 
19 distinct profiles.
In the present study, restriction endonuclease digestion of REP-PCR amplification 
products was carried out to try to differentiate between strain A and strain A* which 
were not discriminated by REP-PCR alone. Of a number of restriction endonucleases 
tried, only Stu I gave a variation in amplification products between strain A and strain 
A* but this approach in conjunction with standard REP-PCR for the other strains 
enabled discrimination of all strains identified from the cows in this project.
The double-crossover design of intramammary infusion with S. aureus allowed study 
of the effects of challenge of an infected quarter with the indigenous or non- 
indigenous strain of S. aureus. Two cows were challenged with the indigenous strain 
of Staphylococcus aureus.
Cow 125 was naturally infected with strain A (LF, LH) and subsequently challenged 
with the indigenous strain A in the LF, and LH quarters. The intramammary infection 
persisted throughout the study in quarters which were previously subclinically infected
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or uninfected. This implied that challenge with a high dose of the indigenous strain 
did not restimulate the immune system which might have resulted in subsequent 
clearance of the infection within the quarter. The identification of additional isolates 
both pre-challenge (LH) and post-challenge (day 17, LF: R2; day 17, RF: R5) indicates 
the presence of more than one strain within an individual quarter. However, in this 
cow, the predominant strain isolated post-challenge remained strain A.
Cow 703 was naturally infected with strain B (LF) and subsequently challenged with 
the indigenous strain in the LF and LH quarters. Strain B was isolated post-challenge 
from the LH quarter (days 3 and 8) and LF quarter (day 3), however, by day 8 post­
challenge, additional isolates R3, R4, R* and R7 were identified in the LF quarter. 
Failure to isolate strain B on day 8 post-challenge may be have resulted from an 
enhanced immune response to the original bacterial strain B eliminating or reducing 
the numbers of this strain, thus allowing different strains to become the predominant 
isolates from this quarter.
Two other cows were challenged with the non-indigenous strain of S. aureus. Cow 
186, was naturally infected with strain A in three of the four quarters and strain A* in 
one quarter and was challenged with the non-indigenous strain B in all four quarters. 
In the quarter with the original infection caused by strain A*, by day 17 post­
challenge a mixed population of strain A, strain A* and strain Ri was detected. Strain 
B was not isolated at any point post-challenge throughout the study.
Cow 520, which was naturally infected with strain B and subsequently challenged 
with the non-indigenous strain A, had the non-indigenous strain isolated as a 
homogenous population on day 3 post-challenge when all isolates tested were shown 
to be strain A. This suggests a transient period of infection by the challenge strain A. 
By day 8 post-challenge, only the indigenous strain was identified in all isolates and 
this was also the case on day 17 post-challenge. The presence of strain B may be a 
result of cross-contamination of strains between cows or quarters. The cows were 
tethered separately to reduce environmental spread and the milking machine clusters
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were disinfected between cows. It is possible that transfer from the RH quarter to the 
RF quarter may have occurred during milking in this cow.
This part of the study showed that when infected with the indigenous strain (either 
strain A or strain B) and subsequently challenged with the non-indigenous strain, the 
indigenous strain persisted as the dominant strain within the quarter and was the only 
strain identified on day 17 post-challenge in most quarters in both cases.
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Chapter 3
3 Inflammation in Staphylococcus aureus 
Mastitis
3.1 Introduction
One of the main aims of this part of the project was to develop a monoclonal 
antibody raised specifically against bovine SAA. In the initial stages of the 
project, SAA concentration in bovine serum samples was assessed by ELISA 
using a polyclonal rabbit anti-human SAA antibody. In order to purify SAA from 
bovine serum an attempt was made to identify specific diseases of cattle which 
might be associated with increased level of this protein. The cattle referred to 
Glasgow University Veterinary School included those affected by a variety of 
infectious, inflammatory or neoplastic conditions. The aim was to measure serum 
haptoglobin levels which had been shown to correlate with SAA levels in diseased 
cattle and to screen sera from a number of these cases using the polyclonal rabbit 
anti-human SAA antibody. In order to prepare antigen for monoclonal antibody 
production, improved methods for isolation and purification of SAA had to be 
developed during this project.
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3.2 Materials and Methods
3.2.1 Identification and Quantification of Acute Phase Proteins 
from Sera of Diseased Cattle
3.2.1.1 Determination of Haptoglobin Concentration
Haptoglobin is one of several proteins associated with the acute phase response 
and is used as an indicator of inflammation and infection. Increased haptoglobin 
levels were detectable in serum within hours of experimental infection of calves 
with Pasteurella haemolytica and were correlated with elevated SAA levels 
(Horadogoda, 1994). The haptoglobin assay was, therefore, used in this project 
to rapidly identify diseased cattle likely to have a high serum amyloid A 
concentration.
Haptoglobin Assay. The haptoglobin assay was a semi-automated method based 
on that of Conner et al. (1988). Stock haemoglobin solution was diluted in 0.9% 
saline to a standard 30mg/ml. All samples, standards and controls were diluted 
1:75 in standard haemoglobin solution and left for 10 minutes at room 
temperature to allow the formation of the haptoglobin-haemoglobin complex. 
Two hundred microlitres of assay reagent (3,3’,5,5’-tetramethylbenzidine (TMB) 
stock of 6mg/ml in DMSO diluted 1:100 in chromogen buffer, 0.5g disodium 
ethylene diamine tetra acetic acid (di-EDTA), 15.6g sodium dihydrogen 
orthophosphate ((NaH2PC>4), pH3.8)) was mixed with 6pl of diluted sample in the 
reaction cuvette. Fifty microlitres of start reagent (0.12% w/v hydrogen 
peroxide) was added and the absorbance measured at 600nm every 25 seconds 
until the reaction end point was reached using a MIRA discrete biochemistry 
analyser (Roche Diagnostics, Welwyn Garden City, Herts). The assay was 
calibrated using a bovine acute phase serum standardised against purified 
haptoglobin.
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3.2.1.2 Determination of Serum Amyloid A Concentration
To obtain sufficient quantities of serum amyloid A (SAA) to use as antigen in 
monoclonal antibody production, serum was collected from diseased cattle 
admitted to the University of Glasgow Veterinary School. Seventeen samples 
with SAA levels greater than 50mg/l were identified by ELISA using a rabbit anti­
human serum amyloid A antibody (Calbiochem-Novabiochem (UK) Limited, 
Nottingham) (Table 3.1). High levels of SAA (>50mg/l) were measured in cattle 
with a wide variety of clinical diseases (Table 3.1). The conditions that the cattle 
were affected by included viral, bacterial and parasitic infections, tumours and 
metabolic disease.
The sera were pooled and high density lipoprotein (HDL) with which SAA is 
associated was isolated by ultracentrifugation thus removing the majority of serum 
proteins. The SAA was further purified by electro-elution of the high density 
lipoprotein fraction following sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) while western blot analysis was used to confirm the 
isolation and purification of the SAA.
3.2.2 Isolation and Purification of Serum Amyloid A
3.2.2.1 Separation of Serum from Blood
Blood samples from diseased cattle described in Table 3.1 were obtained by 
venepuncture of the jugular vein. The sample was incubated at 37°C for 30 
minutes to improve clot retraction and then at 4°C for a further 30 minutes. The 
sample was then filtered to remove the clot and centrifuged at 1900g at room 
temperature for 20 minutes. After centrifugation the serum fraction was carefully 
removed, heat inactivated at 56°C for 30 minutes and stored at -20°C.
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Case
number Diagnosis
SAA
(mg/1)
120942 Cellulitis 195.0
120898 Laryngeal abscess 52.6
120917 Mastitis and hepatitis 50.0
121121 Necrotising pneumonia 85.0
121194 Peritonitis and polyarthritis 92.3
121374 Intestinal carcinoma 68.1
121991 Meningitis and encephalitis 64.0
122058 Oral and interdigital ulceration 72.0
122105 Nephrosclerosis 77.5
122247 Hepatic lipidosis 76.1
122754 Lungworm 78.0
123302 Mucosal disease 82.0
123437 Mucosal disease 81.2
123589 Endocarditis 52.4
123669 Pyelonephritis 58.5
123745 Endocarditis and pulmonary thromboembolism 58.6
123811 Pulmonary thromboembolism/abomasal ulceration 72.3
Table 3.1: Serum amyloid A concentrations in diseased cattle.
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3.2.2.2 Removal of Non-Lipoprotein Serum Proteins
To obtain serum amyloid A for use in the monoclonal antibody production, 
several purification stages were carried out initially to isolate the high density 
lipoprotein fraction and then the SAA from the other apolipoproteins.
To raise the non-protein density of the serum to 1.21g/ml, lOmls of serum was 
mixed with 3.56g of potassium bromide and 6.5ml aliquots were placed in 
thermoplastic ultracentrifuge tubes (Beckman Instruments UK Limited, High 
Wycombe, Buckinghamshire). The tubes were capped, ensuring that air bubbles 
were kept to a minimum, and centrifuged at 190,000g, at 4°C for 48 hours in a 
Beckman L-70 Ultracentrifuge (fixed angle rotor type 50.4 Ti). Following 
centrifugation, the top 1ml fraction of the samples containing the HDL was 
carefully removed by pipette.
Potassium bromide was removed from the SAA fraction by dialysis. Dialysis 
tubing D-9277 (Sigma) was soaked in distilled water for at least 60 minutes 
before use. Fractions from the ultracentrifugation were dialysed against distilled 
water at 4°C for 48 hours. Following dialysis, samples were removed from the 
tubing and placed in sterile universals for lyophilisation. Samples were frozen 
horizontally to achieve the largest surface area possible and then freeze-dried 
overnight.
3.2.2.3 Determination of Total Protein Concentration of Serum
The total protein assay based on bicinchoninic acid reagent (Sigma) was used for 
the determination of total serum protein and also for quantification of SAA after 
purification. Bovine serum albumin (BSA, 2mg/ml in 0.15M NaCl with 0.05% 
sodium azide) was used as a standard at a range of concentrations from 0-2mg/ml. 
Dilutions were performed in distilled water. Ten microlitres of the standard and
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the samples and 200pl of assay reagent (1 part copper (II) sulphate (pentahydrate 
4% (w/v) solution ) mixed with 50 parts bicinchoninic acid solution) were 
incubated in a 96-well mictotitre plate (Microtitre plates, Greiner) at 37°C for 30 
minutes. Following incubation the absorbance was read at 562nm using a 
MR5000 ELISA reader (Dynatech) and protein concentration calculated from the 
BSA calibration curve.
3.2.2.4 Separation of Serum Amyloid A from High Density Lipoproteins
Further purification of SAA was required for monoclonal antibody production. 
Following ultracentrifugation, dialysis and lyophilisation the semi-purified SAA 
was still associated with HDL. Serum Amyloid A was separated from other HDL 
apolipoproteins by SDS-PAGE followed by electro-elution in order to increase 
the immunogenicity of the SAA, as fewer antigenic determinants of the SAA are 
exposed in the native state (Godenir etal., 1985; Sipe etal., 1989).
SDS-PAGE gel and samples were prepared as described previously in the Large 
Gel System. Electro-elution was performed using the Bio-Rad Model 422 
Electro-eluter. Prior to electro-elution, membrane caps were placed in elution 
buffer (25mM Tris-base, 192mM glycine and 0.1% SDS) at 60°C for at least 60 
minutes. After heating, membrane caps were stored in elution buffer, which 
contained 0.05% sodium azide as a preservative, at 4°C. After electrophoresis, 
the gel was washed three times in deionised water and then stained for 10 minutes 
using 0.1% coomassie brilliant blue in 25% methanol, 10% acetic acid and 1% 
glycerol. The stained gel was washed in distilled/deionised water for two hours, 
or until the protein bands became clearly visible. After washing the SAA band 
was identified on the basis of molecular weight and a narrow strip of gel 
incorporating the band was removed. The gel segment was then cut into 5mm x 
5mm squares and stored in elution buffer at 4°C until electro-elution. The gel 
squares were placed in the glass chambers within the electro-eluter module and 
eluted at 8-10mA per chamber in protein elution buffer for approximately five 
hours on ice, after which the sample was dislodged from the membrane caps by
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rinsing with 200pl of fresh elution buffer and stored a 4°C until the concentration 
stage. Alternatively, a narrow strip of stained gel was used as a template for 
locating the SAA region from the unstained portion of a gel and samples were 
electro-eluted as before.
3.2.2.5 Concentration of Serum Amyloid A
Concentration of the eluate from electro-elution was carried out using Centricon 3 
Microconcentrators (Amicon Limited, Stonehouse, Gloucestershire) and stored at 
-20°C. Eluate was tested using SDS-PAGE gel electrophoresis to determine 
purity and the protein concentration was assessed using the BCA protein assay.
3.2.3 Identification of Serum Amyloid A
3.2.3.1 Enzyme Linked Immunosorbent Assay
To determine the SAA concentration in serum samples an ELISA was used 
(Horadogoda et al, 1994). The standard used for this assay was a bovine serum 
sample which had previously been quantified for SAA and haptoglobin levels. 
The standard contained 200pg/ml of SAA and was diluted with fetal calf serum 
(FCS) to give a range of SAA concentrations between 0-200pg/ml to establish a 
calibration curve.
Standards, test samples and a control sample which was a ‘normal’ serum sample 
containing negligible SAA were all diluted 1:400 in coating buffer (lOmM sodium 
bicarbonate (NaHC0 3 )/sodium carbonate (Na2 CO3), pH 9.6). One hundred 
microlitres was dispensed in duplicate into wells of a 96 well flat bottom 
microtitre plate (Greiner Labortechnik Limited, Stonehouse, Gloucestershire). 
The microtitre plate was incubated at room temperature (20-22°C) for eighteen 
hours to allow the samples to bind to the plate. The fluid was then decanted and 
the plates rinsed three times with phosphate buffered saline-Tween 20 (PBS-T,
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20mM NaH2P0 4 , 20 mM disodium hydrogen monophosphate (Na2 P0 4 ), 154mM 
sodium chloride (NaCl) and 0.05% (v/v) Tween-20 ), at pH 7.4.
To reduce non specific protein binding, 300(4.1 of 10% (w/v) dried skimmed milk 
in PBS-T was added to each well and incubated at room temperature for sixty 
minutes. Following incubation each well was washed three times with PBS-T.
Rabbit anti-human serum amyloid A (Calbiochem-Novabiochem (UK) Limited, 
Nottingham) was prepared at a 1:10,000 dilution in PBS-T and lOOpl was added 
to each well. The plate was then incubated at room temperature for ninety 
minutes, and washed three times in PBS-T to ensure complete removal of any 
excess primary antibody solution.
Horseradish peroxidase-conjugated donkey anti-rabbit IgG (Scottish Antibody 
Production Unit, Law Hospital, Carluke) was prepared at a 1:2500 dilution in 
PBS-T and lOOfil was added to each well, incubated at room temperature for 
ninety minutes, and washed thoroughly three times in PBS-T.
Peroxidase substrate (0.01M acetate buffer, (pH5.5), 0.04% hydrogen peroxide, 
and 0.1% TMB in dimethyl sulfoxide) was freshly prepared and 150pl was added 
to each well and incubated at 37°C for 15 minutes. The substrate reaction was 
terminated by the addition of 50|j.l of 2M sulphuric acid to each well.
The absorbance was measured at 450nm using a plate reader (Dynatech MR5000, 
Dynatech Laboratories Limited, Billinghurst, West Sussex) and converted to SAA 
concentration by the immuno assay software.
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3.2.3.2 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis.
Serum amyloid A was identified by molecular weight using sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) stained with coomassie 
brilliant blue. The identification of SAA was confirmed by immuno blot analysis 
using antibodies specific for human SAA previously shown to cross react with 
bovine SAA (Horadogoda, 1994).
Mini-Gel System. Standards, controls and test samples were diluted 1:20 in 
distilled/deionised water. The wide range molecular weight marker (M.W. 6,500- 
205,000, Sigma-Aldrich Company Limited, Poole, Dorset) and samples were 
mixed 1:1 with treatment buffer (0.125M Tris-Cl, (pH 6.8), 4% sodium dodecyl 
sulphate (SDS), 20% glycerol and 10% 2-mercaptoethanol) and boiled at 100°C 
for 2-3 minutes to denature the protein structure by reduction of disulphide 
bonds. Samples were then centrifuged at 13800g using a Eppendorf 5415 
centrifuge (Eppendorf limited, Hamburg) for 30 seconds.
SDS-PAGE resolving gel solution (0.375M Tris-HCl, (pH8.8) 0.1% SDS; 0.1% 
(w/v) ammonium persulphate (APS); 0.07% N, N, N ’, N ’-tetremethyl- 
ethylenediamine (TEMED) and 15% bis acrylamide) was prepared and added to 
the gel apparatus (8.0cm x 7.3cm x 0.75cm, Biorad Minigel System, Biorad 
Laboratories Limited, Hemel Hempstead) adding a barrier layer of 70% propanol 
to aid the formation of the gel matrix. When the resolving gel had solidified at 
room temperature, the gel was washed with distilled water to remove the 
propanol. The stacking gel (0.125M Tris-HCl, (pH6.8) 0.1% SDS; 0.05% (w/v) 
APS, 0.05% TEMED, 4% bis acrylamide) was added, inserting the combs 
carefully. The combs were removed, gel apparatus was placed in the gel tank 
(Biorad - Mini Protean II cell) and the central well filled with tank buffer (0.025M 
Tris, (pH8.3), 0.192M glycine and 0.1% SDS). Tank buffer was also added into 
the buffer tank. Fifteen microlitres of molecular weight marker and 20jj1 of each 
sample was loaded into each gel and electrophoresed at 200V for 60 minutes.
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After electrophoresis, one gel was removed and placed in coomassie stain 
(0.125% coomassie blue R-250, 50% (v/v) methanol, 10% (v/v) acetic acid) for 
5-10 minutes, followed by destaining in destain (5% (v/v) methanol, 7% (v/v) 
acetic acid) for 20 minutes, while a duplicate gel was processed by 
immunoblotting.
Large Gel System. The method used was similar to the mini-gel system except 
that the gel dimensions used were 16cm x 20cm x 1.5mm and larger sample 
volumes (60pl per well) were loaded. The gel was electrophoresed for three 
hours at 200 Volts.
3.2.3.3 Immuno Blotting
The duplicate SDS-PAGE gel (unstained) was used for the Immuno Blotting 
technique. Nitrocellulose membrane (Transblot Transfer medium, 0.45pm, 
Biorad) (1 piece) and filter paper (1 piece) were prepared before use by soaking in 
transfer buffer (25mM tris, 192mM glycine and 20% (v/v) methanol).
The SDS-PAGE gel was placed between the filter paper and nitrocellulose 
membrane in the transfer plates. The plates were covered with transfer buffer and 
electrophoresed at 100V for 30 minutes. After transfer, the nitrocellulose 
membrane was blocked overnight with 5% (w/v) dried skimmed milk solution in 
Tris buffered saline-Tween 20 (TBS-T, lOmM Tris-Cl (pH8.2), 150mMNaCl and 
0.5% Tween 20) on a rotatest shaker (Luckham R100, Luckham Limited, Sussex) 
at 4°C. After blocking, the nitrocellulose membrane was rinsed three times in 
approximately 50mls of TBS-T. Fifty millilitres of antibody solution (rabbit anti­
human SAA, Calbiochem) was added at 1:1000 in TBS-T, and incubated on a 
rotatest shaker for 60 minutes at room temperature. The antibody solution was 
then removed and the nitrocellulose membrane was rinsed three times with TBS- 
T. To ensure complete removal of excess antibody solution a further two, 10 
minute, washes in 50mls of TBS-T were carried out. Fifty millilitres of secondary
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antibody (donkey-anti-rabbit IgG labelled with horseradish peroxidase) was added 
at 1:1000 in TBS-T and incubated for 60 minutes on the shaker. The 
nitrocellulose membrane was then rinsed and washed in TBS-T as above. Amino 
ethyl carbazole (AEC) substrate (20mg AEC dissolved in 2.5ml dimethyl 
formamide and added to 0.05M acetate buffer (pH5) to give a final volume of 
50ml, plus lOOpl of 30% hydrogen peroxide solution) was freshly prepared and 
poured onto the blot and incubated for 5-15 minutes. The blot was then washed 
in distilled water to terminate the reaction and dried.
3.2.3.4 Immuno Dot-Blot
The immuno-dot blot was used as a rapid, semi-quantitative method for 
identifying samples with elevated SAA. Ten microlitre aliquots of the samples 
and the standards were added in duplicate to nitrocellulose membrane and allowed 
to air dry at room temperature. The nitrocellulose membrane was blocked with 
5% (w/v) dried skimmed milk in TBS-T for two hours on a rotatest shaker at 
room temperature. Following incubation the method was as described previously 
for the immunoblotting technique (after the blocking procedure stage).
3.2.4 Identification and Quantification of Acute Phase Proteins in 
Milk Samples from Mastitic Cows
3.2.4.1 Determination of Haptoglobin Concentration
To determine if acute phase proteins could be detected in milk, the concentration 
of haptoglobin was determined using a modification of the semi-automated 
haptoglobin assay. Stock solutions were used at concentrations described as for 
detection of haptoglobin from bovine sera unless otherwise stated. The 
haptoglobin standard (bovine acute phase serum of known haptoglobin 
concentration) was diluted in normal serum (negligible haptoglobin) to give a 
range of concentrations from 0.3mg/ml to 3.0mg/ml. Twenty microlitres of the
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standards, controls and samples were then placed in test tubes, IOOjj,! of standard 
haemoglobin solution was added and the samples were mixed thoroughly and 
incubated at room temperature for 10 minutes. Five millilitres of 0.9% saline was 
added to the tubes, mixed, and then 20jj.l of the sample was pipetted in duplicate 
into a 96-well microtitre plate (Greiner). Two hundred microlitres of chromogen 
solution was added and the plate incubated at 37°C for 60 minutes. Fifty 
microlitres of substrate was added and the samples were then incubated at room 
temperature until adequate colour development had occurred in the standard 
samples. The reaction was terminated by adding 50|il of 20% sulphuric acid and 
the absorbance was read at 450nm using an MR5000 plate reader (Dynatech). 
The haptoglobin concentrations were calculated by comparison to the standard 
haptoglobin solution.
3.2.4.2 Determination of Serum Amyloid A Concentration
SAA concentrations in milk samples were determined by ELISA as described 
previously for SAA in bovine sera. The concentrations of samples, primary 
antibody and secondary antibody were varied to determine the optimum assay 
conditions. Due to the original antibody being unavailable due to an alteration in 
the manufacturing procedures, other possible antibodies had to be assessed to 
attempt to and find a suitable replacement for detecting bovine SAA. The 
alternative antibodies were assessed initially with a serum standard with a known 
SAA concentration by ELISA, SDS-PAGE and immunoblotting, using the 
method described for measurement of SAA in sera. Primary antibody 
concentrations varying from 1:1000 to 1:20,000 were incubated with samples 
diluted in coating buffer from 1:100 to 1:1,200 to try to optimise the assay. The 
antibodies assessed by ELISA, SDS-PAGE and immunoblotting were: rabbit anti­
human serum amyloid A component, non-precipitating, (Calbiochem) and a rat 
monoclonal anti human SAA, (2° antibody-rat anti IgG HRP labelled, (Biosource 
International, Serotec, Kidlington, Oxford). A rabbit anti-bovine AA and a rabbit 
anti-bovine SAA kindly provided by Professor Gruys, Utrecht University, The 
Netherlands were analysed by SDS-PAGE and immunoblotting.
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3.2.5 Development of a Monoclonal Antibody to Serum Amyloid A
The techniques attempting to develop a monoclonal antibody to purified SAA 
were carried out by Rhone Poulenc Diagnostics Limited, West of Scotland 
Science Park, Maryhill Road, Glasgow. Collaboration with colleagues from 
Rhone Poulenc took place throughout the purification stages and the 
immunisation procedure for antibody production.
3.2.5.1 Immunisation of Mice with Bovine Serum Amyloid A
The initial immunisation procedure used purified SAA at a concentration of 
180(ig/ml in elution buffer (24mM tris, 0.19M glycine and 0.02% SDS). The 
SAA was obtained by the electro-elution method described previously where the 
SDS-PAGE gel was partially stained with coomassie to identify the SAA rich 
portion. This resulted in the coomassie stain binding to the SAA which remained 
even following elution.
A group of 3 BALB/c mice were given a subcutaneous injection of lOOpl of 
immunogen which contained 50}ig of antigen in an emulsion prepared with 
complete Freund’s adjuvant. Twenty one days later, lOOpl of immunogen 
containing 20fig of antigen in an emulsion of incomplete Freund’s adjuvant was 
injected subcutaneously and repeated 14 days later. Approximately 7 days after 
the third subcutaneous immunisation a test bleed was carried out to determine if 
an antibody response had occurred. A sample of blood was removed from the tail 
vein and allowed to clot, serum was removed after centrifugation and the serum 
antibody titre tested by ELISA with SAA bound to the wells of the microtitre 
plates.
In monoclonal antibody production if a good antibody response occurs the 
animals are rested and then boosted by a intravenous injection of antigen in saline, 
with the removal of the spleen and blood occurring 4 days later, followed by
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fusion of spleen cells. However if a poor antibody response occurs then re- 
immunisation with antigen is generally performed.
Due to the poor antibody response of the mice after the initial immunisation with 
SAA (coomassie bound) a second immunisation with purified SAA (184pg/ml in 
elution buffer) which had been isolated using the alternative electro-elution 
method, and therefore, free of the coomassie stain, was carried out.
3.2.5.2 Immunisation of Mice with Bovine Serum Amyloid A-Apoferritin 
Complex
SAA is a relatively small molecular weight protein (approximately 12.5kDa). A 
good immune response to the antigen may not occur due to poor antigenicity of a 
small protein. To improve the immune response of small immunogens a carrier 
protein may be attached which will increase the size of the immunogen and may 
provide the binding sites essential for an immune reaction. An additional 
immunisation technique used SAA bound to apoferritin, a carrier protein isolated 
from horse spleen, to try to improve the immune response of the animals to the 
SAA by increasing the molecular mass of the immunogen.
Purified SAA was desalted and concentrated using centricon 3 
microconcentrators (Amicon Limited) with 50mM triethanolamine, 0.15M sodium 
chloride, 2mM EDTA, (pH 8.0) to a final volume of 0.3ml. Freshly prepared 2 
iminothiolane, a protein modification reagent, was mixed with bovine SAA under 
nitrogen at room temperature for 45 minutes and desalted through a precalibrated 
PD10 column of G25 sephadex (Pharmacia Limited, Milton Keynes) with 0.083M 
sodium phosphate, 0.9M sodium chloride, 0.1M EDTA, (pH7.2) and the eluted 
peak of labelled SAA collected.
Two milligrams of the carrier protein apoferritin was mixed with 300pi of 
PBS/EDTA. Four-(N maleimidomethyl) cyclohexane carboxylic acid N-hydroxy 
succinimide ester (SMCC) was mixed with dimethylsulfoxide (DMSO) and
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combined with the apoferritin solution at room temperature for 30 minutes and 
desalted again through a PD10 column and the purified peak of apoferritin 
collected. The desalted fractions of modified SAA and apoferritin were mixed 
and allowed to react overnight at 4°C. All traces of EDTA were removed from 
the protein conjugate by centrifugation in centricon 3 microconcentrators and 
buffer exchange with PBS until a final volume of 1ml was obtained.
The immunisation procedure was similar to the initial protocol described above, 
with the exception that 4 BALB/c mice were immunised with bovine SAA- 
apoferritin complex. The first and second immunisations involved the 
subcutaneous injection of lOOpl of immunogen containing 100|ig of apoferritin 
and 20fig SAA prepared as an emulsion in Freund’s adjuvant (1st immunisation - 
complete adjuvant, 2nd - incomplete adjuvant). A third subcutaneous injection 
containing 50|ig of apoferritin and lOfig of SAA in Freund’s incomplete adjuvant 
was carried out. A test bleed to determine the antibody titre was taken before the 
animals were boosted, with a 200pl intravenous injection containing 25jig of 
apoferritin and 5fig of SAA in saline.
3.2.5.3 Measurement of Antisera Response to Immunisation of Mice with 
Bovine Serum Amyloid A
An ELISA assay was developed to measure the antisera response to immunisation 
of mice with bovine serum amyloid A. Microtitre plates were coated with purified 
bovine SAA and the serum response measured from the immunised mice using 
non-immunised mouse serum as a control. The bound antibody was detected 
using an anti-mouse IgG-horseradish peroxidase labelled antibody (Sigma) with 
TMB as a substrate.
The immuno dot blot technique was used as a more sensitive method of 
determining the antibody response of the mice. The streptavidin/biotin system 
was used to determine if any significant response had occurred as this system is 
more sensitive than other detection procedures and can be used accurately for the
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detection and localisation of antigens, glycoconjugates and nucleic acids. Dot 
blot analysis was carried out using 2\x\ sample volumes with serial dilutions of the 
purified standard SAA, high and low serum SAA standards and 1:250 dilutions of 
the mouse control serum and test samples. Anti-mouse IgG biotin labelled 
antibody (Sigma) was used followed by streptavidin labelled HRP. Bound 
peroxidase was detected after washing with the substrate 4 chloro, 1 naphthol.
3.3 Results
3.3.1 Identification and Quantification of Acute Phase Proteins 
from Sera of Diseased Cattle
A bovine serum sample of known SAA concentration was used as a standard 
allowing construction of a calibration curve and determination of the SAA 
concentration in the unknown serum samples using a polyclonal rabbit anti-human 
SAA antibody. Cattle affected by conditions which the farm animal clinicians at 
Glasgow Veterinary School considered to involve a significant inflammatory 
response failed to consistently show elevated levels of SAA in ELISA using the 
polyclonal rabbit anti-human SAA antibody. It was, therefore, not possible to 
select animals with high SAA on clinical criteria. Previous work by Horadogoda 
et al. (1994) had shown that SAA levels were related to haptoglobin levels in 
cattle, but that the SAA was raised in a number of samples where haptoglobin was 
normal. However, haptoglobin levels in these selected cases varied from normal 
(less than 0.1 mg/ml) to increased (3.06mg/ml) indicating that haptoglobin levels 
were not consistently elevated in all animals with high SAA. Blood samples from 
all cattle cases were subsequently screened for SAA and cases were then selected 
on the basis of having a SAA concentration of > 50mg/l and these included a 
variety of infectious and inflammatory conditions (Table 3.2).
93
3.3.2 Determination of Serum Amyloid A Concentration
A calibration curve for bovine SAA measured by ELISA was constructed by 
dilution of an acute phase serum standard with a SAA concentration of 192pg/ml 
in FCS to give a range of concentrations from approximately 0-192pg/ml (Table 
3.3; Figure 3.1).
3.3.2.1 Isolation and Purification of Serum Amyloid A
In order to obtain SAA for use in monoclonal antibody production, the SAA had 
to be purified, which involved a number of isolation stages and confirmation of 
the presence of the SAA after each purification step.
The initial purification of SAA from serum involved ultracentrifugation of the 
samples which separated the serum into density determined fractions containing 
very low density proteins, low density proteins, medium density proteins and high 
density proteins which were designated fractions 1-4 respectively. The BCA total 
protein assay gave typical results as shown in table 3.4 and in figure 3.2 and was 
used for determination of total protein content of fractions 1-4 (Table 3.5).
3.3.2.2 Identification of Serum Amyloid A
To assess the presence of SAA in serum, SDS-PAGE was used to identify the 
SAA, which is a 12.5 kilodalton protein (Betts et al., 1991) and can be identified 
by comparison with molecular weight (MW) standards which ranged from M.W. 
6,500 to 205,000. The presence of SAA was also confirmed by comparison with 
serum samples known to contain negligible, or high levels of SAA, which were 
used as negative and positive controls respectively.
Following identification of SAA by molecular weight, the presence of SAA was 
confirmed by immunoblotting using the polyclonal rabbit anti-human SAA
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Case
number Diagnosis
SAA
(mg/1)
Hp
m
120942 Cellulitis 195.0 1.4
120898 Laryngeal abscess 52.6 <0.06
120917 Mastitis and hepatitis 50.0 <0.06
121121 Necrotising pneumonia 85.0 0.8
121194 Peritonitis and polyarthritis 92.3 <0.06
121374 Intestinal carcinoma 68.1 0.06
121991 Meningitis and encephalitis 64.0 0.24
122058 Oral and interdigital ulceration 72.0 <0.06
122105 Nephrosclerosis 77.5 0.36
122247 Hepatic lipidosis 76.1 <0.06
122754 Lungworm 78.0 2.34
123302 Mucosal disease 82.0 1.68
123437 Mucosal disease 81.2 2.34
123589 Endocarditis 52.4 1.92
123669 Pyelonephritis 58.5 3.06
123745 Endocarditis and pulmonary thromboembolism 58.6 <0.06
123811 Pulmonary thromboembolism/abomasal ulceration 72.3 1.62
Table 3.2: Serum haptoglobin concentrations in diseased cattle with SAA levels 
>50mg/l referred to Glasgow University Veterinary School. SAA = serum 
amyloid A. Hp = haptoglobin, haptoglobin reference range < 0.3mg/ml for 
normal animals.
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SAA Concentration (^ig/ml) Mean Absorbance (450nm)
192 0.951
96 0.691
48 0.536
19.2 0.402
9.6 0.230
0 0.047
Table 3.3: Standard SAA (concentration 192|ig/ml) used for the construction of a 
calibration curve for bovine SAA measured by ELISA. The average absorbances 
of 10 curves at 450nm are shown. SAA = serum amyloid A.
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BSA Concentration 
(mg/ml)
Mean Absorbance (562nm)
2.0m g/ml 0.997
1.5mg/ml 0.830
1.0 mg/ml 0.606
0.5mg/ml 0.352
0.0 0.050
Table 3.4: Standard BSA (concentration 2.0mg/ml) used for the construction of a 
calibration curve for total protein measured by BCA total protein assay. The 
average absorbances of 10 curves at 562nm are shown. BCA = bicinchoninic acid
98
To
ta
l 
Pr
ot
ein
 
C
al
ib
ra
tio
n 
C
ur
ve
04 O04
CM
ID
lO
O
O)
E
c
o
aS
+ - •ca)
oco
o
<
CO
00
o  o  o  o
(ujuggg) eoueqjosqe
99
Fi
gu
re
 
3.
2:
 C
al
ib
ra
tio
n 
cu
rv
e 
for
 
BC
A 
to
ta
l 
pr
ot
ein
 
as
sa
y
Sample Dilution Average
Absorbance
(562nm)
Total Protein 
Concentration 
(g/1)
Fraction 1 1:10 0.354 5.08
Fraction 2 UNDIL 0.690 1.17
Fraction 3 1:100 0.445 67.10
Fraction 4 1:1000 0.299 412.00
Table 3 .5: The average absorbances for each fraction following ultracentrifugation 
are shown. Total protein concentration calculated from BCA total protein assay 
using BSA calibration data. BSA = bovine serum albumin. UNDIL = undiluted 
sample. BCA = bicinchoninic acid
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antibody. Positive and negative control sera were also immunoblotted to confirm 
the specificity of the rabbit anti-human SAA for bovine SAA.
The SAA with a molecular weight of approximately 12,500 Daltons was identified 
in fraction 1 (high density lipoprotein fraction (HDL)) after SDS-PAGE (Figure 
3.3) and immunoblotting (Figure 3.4). SAA was also identified in fraction 2 
(medium density proteins) at a lower concentration. Fractions 3 and 4 (low and 
very low density proteins respectively) contained no SAA.
The SAA fraction was further purified by dialysis to remove any remaining K-Br 
and then freeze dried. The presence of SAA was again confirmed by SDS-PAGE 
(Figure 3.5) and immunoblotting (immunoblots not shown).
Electro-elution of the SAA containing fraction which had been semi-purified by 
ultracentrifugation, dialysis and lyophilisation was used to further purify the SAA. 
The electro-elution was carried out on three separate occasions to further purify 
three batches of semi-purified SAA. Following electro-elution the SAA was 
concentrated to approximately 200pg/ml, determined using the BCA total protein 
assay (Table 3.6). The purified SAA was then checked for purity by SDS-PAGE 
and immunoblotting where the band isolated showed positive staining as in Figure
3.4 (results not shown).
3.3.3 Development of a Monoclonal Antibody to Bovine Serum 
Amyloid A
3.3.3.1 Immunisation of Mice with Bovine Serum Amyloid A
The sera from mice immunised with SAA were analysed using an immuno dot blot 
and the streptavidin/biotin system. No colour development was detected in serum 
samples from mice immunised with the purified bovine SAA, at any of the 
dilutions of sera assessed.
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Figure 3.3: SDS-polyacrylamide gel (15%) electrophoresis of acute phase bovine 
serum fractions following ultracentrifugation. Lane 1 shows fraction 1 (HDL 
fraction containing SAA). Lane 2 shows fractions 2 (medium density proteins) 
which contains SAA at a lower concentration than fraction 1. Lanes 3 and 4 
show fractions 3 and 4 respectively which contain no SAA. Lane 5 shows the 
standard serum which contained SAA at a concentration of 192pg/ml.
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Figure 3.4: Immunoblot after SDS-PAGE of acute phase bovine serum fractions 
following ultracentrifugation. Polyclonal rabbit anti-human SAA was used as the 
primary antibody. Lane 1 shows the standard serum which contained SAA 
(concentraion 192p.g/ml). Lane 2 shows fraction 2 (medium density protein 
fraction) which contains SAA. Lane 3 shows fraction 1 (HDL fraction) with the 
SAA region clearly identified by the immunoblot.
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Figure 3.5: Coomassie stained SDS-polyacrylamide gel (15%) electrophoresis of 
the HDL portion of acute phase serum following ultracentrifugation, dialysis and 
lyophilisation at a range of dilutions. Lanes 1 -4, shows the fraction 1 with SAA 
identified by comparison with the MW marker at dilutions of fraction 1 of 1:16, 
1:8, 1:4 and 1:2 respectively. Lane 5 shows the standard SAA (concentration 
192|ig/ml).
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Electro-elution Average Absorbance Total Protein
(562nm) (Hg/ml)
1 0.228 227
2 0.297 229
3 0.231 184
Table 3.6: Total protein concentration of electro-eluates 1, 2 and 3 using the 
BCA total protein assay.
i
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3.3.3.2 Immunisation with Bovine Serum Amyloid A-Apoferritin Complex
The sera from mice immunised with serum SAA-apoferritin complex was analysed 
using ELISA. No colour development was detected in serum samples from mice 
immunised with the purified bovine SAA-apoferritin complex, at any of the 
dilutions of sera assessed.
These two approaches to produce a monoclonal antibody to bovine SAA were 
unsuccessful and it was not possible to attempt further immunisation regimes 
within the duration of the project.
3.3.4 Identification and Quantification of Acute Phase Proteins in 
Milk Samples From Mastitic Cows
Milk samples were taken from the four cows challenged by intramammary 
infusion with S. aureus (cows 125, 186, 520 and 703), but only from the hind 
quarters (LH and RH) on four separate dates, i.e. days 0 (pre-challenge), 4, 8 and 
17 post-challenge.
3.3.4.1 Quantification of Total Protein and Haptoglobin
The skimmed milk fraction was analysed to determine the total protein 
concentration using the total protein assay described for serum. The same 
samples used for total protein measurements were also used to assess haptoglobin 
levels (Tables 3.7 - 3.10). Normal serum haptoglobin levels are <0.10g/l and a 
serum haptoglobin level of >0.40g/l is indicative of infection (Makimura and 
Suzuki, 1982; Skinner et a l , 1991). The haptoglobin assay detection limit was 
between 0.10g/l and 0.14g/l.
All quarters sampled in three of the four cows on all sample dates, had either very 
low concentrations of haptoglobin or levels of haptoglobin which were below the 
limit of detection of the assay (tables 3.7-3.9). A haptoglobin concentration of
106
0.50g/l was measured on day 8 post-challenge in the LH quarter of cow 703 
which was non-infected and which had been challenged with strain B. The 
concentration of haptoglobin in this quarter was not elevated on day 4 and day 17 
post-challenge (table 3.10).
3.3.4.2 Detection of Serum Amyloid A
Alternative antibodies were assessed for their ability to detect bovine SAA due to 
the unavailability of the original rabbit anti-human SAA from Calbiochem. The 
polyclonal rabbit anti-human serum amyloid A component (non-precipitating) 
(Calbiochem) and monoclonal rat anti-human SAA (Biosource International) 
antibodies were assessed by ELISA, SDS-PAGE and immunoblotting using serum 
standards with known concentrations of SAA. Both antibodies gave a 
disappointing result with the ELISA showing no significant increase in absorbance 
in the positive control serum compared to the negative control serum. High 
background also occurred and this was reduced by changing the blocking agent to 
2% BSA in PBS-T, and diluting the primary antibody in 0.1% BSA in PBS-T. 
Following SDS-PAGE and immunoblotting, the monoclonal rat anti-human SAA 
gave a weak positive result for all the proteins in the serum sample and was not 
specific for bovine SAA. The polyclonal rabbit anti-human SAA component, 
(non-precipitating) antibody was also shown to be non-specific for bovine SAA. 
The monoclonal rabbit anti-bovine AA and the monoclonal rabbit anti-bovine 
SAA antibody (kindly donated by Professor Gruys, Utrecht, Netherlands) both 
gave very poor responses to bovine SAA on immunoblotting, however a weak but 
specific response to bovine SAA on immunoblotting was just detectable using the 
rabbit anti-bovine SAA.
Due to the lack of a reliable antibody for detection of bovine SAA, SDS-PAGE 
was performed to determine whether SAA was present in milk. As SAA has a 
characteristic MW of approximately 12,500 and can be observed in SDS-PAGE 
gels of acute phase serum, identification of a protein of identical size to SAA not 
present in normal milk, but detectable in milk after infection or inflammation could 
suggest the presence of SAA in milk. Initially, cow 703 was studied as she had
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Cow
Number
Sample
day
LH Quarter
Infected Strain A 
Challenged Strain A
RH Quarter
Control
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
125 00 < LD 8.40 0.16 12.20
125 04 < LD 12.40 < LD 11.50
125 08 0.20 9.10 0.17 9.80
125 17 < LD 7.30 0.15 9.70
Table 3.7: Haptoglobin and total protein concentrations identified in mammary 
secretions from the hind quarters of cow 125 days 0 (pre-challenge), 4, 8 and 17 
post-challenge. LD indicates limit of assay detection which is <0.10g/l. LH = left 
hind. RH = right hind.
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Cow
Number
Sample
Day
LH Quarter
Infected Strain A 
Challenged Strain B
RH Quarter
Control
Haptoglobin
(rag/ml)
Total protein 
(mg/ml)
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
186 00 0.12 5.00 0.15 13.50
186 04 0.15 11.90 0.18 13.90
186 08 0.18 11.70 0.15 6.2
186 17 0.19 17.30 0.21 16.00
Table 3.8: Haptoglobin and total protein concentrations identified in mammary 
secretions from the hind quarters of cow 186, days 0 (pre-challenge), 4, 8 and 17 
post-challenge. LH = left hind. RH = right hind.
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Cow
Number
Sample
day
LH Quarter
Control
RH Q uarter
Infected Strain B 
Challenged Strain A
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
520 0 0.14 14.00 0.18 12.70
520 4 0.14 11.70 0.19 14.20
520 8 0.15 14.50 NS NS
520 17 0.13 13.70 0.19 20.60
Table 3.9: Haptoglobin and total protein concentrations in mammary secretions 
from the hind quarters of cow 520 days 0 (pre-challenge), 4, 8 and 17 post­
challenge. LH = left hind. RH = right hind. NS = no sample.
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Cow
Number
Sample
day
LH Quarter
Challenged Strain B
RH Quarter
Control
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
Haptoglobin
(mg/ml)
Total protein 
(mg/ml)
703 0 NS NS 0.16 20.05
703 4 0.22 15.50 0.22 14.25
703 8 0.50 26.80 NS NS
703 17 0.17 14.2 0.13 11.5
Table 3.10: Haptoglobin and total protein concentrations in mammary secretions 
from the hind quarters of cow 703 days 0 (pre-challenge), 4, 8 and 17 post­
challenge. LH = left hind. RH = right hind. NS = no sample.
I l l
shown an increase in haptoglobin levels in the LH quarter on day 8 post­
challenge. Samples from both the LH and RH quarters were analysed by SDS- 
PAGE from the four sampling dates i.e., days 0 (pre-challenge), 4, 8 and 17 post­
challenge.
A protein of similar molecular weight to SAA was detected in the LH quarter of 
cow 703 on day 8 post-challenge and this protein was not present in any other 
sample days (Figure 3.6; lane 5). The ‘suspected’ SAA was identified by 
molecular weight and compared to the semi-purified SAA, confirming the 
presence of a protein of similar MW to SAA in milk samples. This approach was 
thought to be as accurate as possible in the absence of a specific antibody for use 
in confirming SAA by immunoblotting. To confirm that this additional protein 
band was probably SAA a negative control milk sample was mixed with a range 
of concentrations of SAA purified from serum. An additional band was observed 
at SAA concentrations of 120mg/l and 60mg/l which was at a similar position in 
the SDS-PAGE milk gel as the additional protein previously identified (figure 
3.7). Figure 3.8 shows a negative control milk sample from the RH quarter on 
day 3 post-challenge and a milk sample from the LH quarter of cow 703 on day 8 
post-challenge which contains a protein of similar molecular weight to SAA. The 
purified SAA and the milk sample which was mixed with the serum SAA all show 
a protein with similar molecular weight to SAA.
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Figure 3.6: Coomassie stained SDS-polyacrylamide gel (15%) electrophoresis of 
milk samples from cow 703 on days 0, 4, 8 and 17 post-challenge from the LH 
and RH quarters. Semi-purified SAA was used as a control in the identification of 
similar molecular weight proteins. Lane 1 shows MW marker. Lane 2 shows RH 
quarter day 3 post-challenge. Lanes 3 and 4 show LH and RH quarters 
respectively from day 4 post-challenge. Lane 5 shows LH sample from day 8 
post-challenge. Lane 6 and 7 show LH and RH samples from day 17 post­
challenge. Lane 8 shows semi-purified SAA. T indicates the ‘suspected SAA’.
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Figure 3.7: Coomassie stained SDS-polyacrylamide gel (15%) electrophoresis of a 
control milk sample ‘spiked’ with a range of concentrations of semi-purified SAA. 
Lane 1 shows MW marker. Lane 2 shows semi-purified SAA. Milk samples 
‘spiked’ with SAA at concentrations of 120mg/l (lane 3) and 60mg/l (lane 4). 
Milk samples ‘spiked’ with SAA at concentrations of 30 (lane 5), 15 (lane 6) and 
Omg/1 (lane 7) respectively. T indicates the ‘suspected SAA’
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Figure 3.8: Coomassie stained SDS-polyacrylamide (15%) electrophoresis. Lane 
1 shows MW marker. Lanes 2 shows a negative control milk sample (RH, day 3 
post-challenge). Lane 3 shows semi-purified SAA. Lane 4 shows a suspected 
SAA milk sample (LH, cow 703, day 8 post-challenge). Lane 5 shows a ‘spiked’ 
milk sample with an SAA concentration of 120mg/l. T indicates the ‘suspected 
SAA’.
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I3.4 Discussion
Identification of the presence of pathological lesions resulting from infectious or 
inflammatory disease in cattle has been shown to be possible by monitoring APP 
such as SAA and haptoglobin (Alsemgeest et a l, 1994; Gruys et a l,  1993). 
Measurement of APP, which remain elevated for hours or days, to quantify 
disease activity is more useful than measuring cytokines which are rapidly cleared 
from the circulation (Hoi et al., 1987). Assays for APP, particularly SAA, may 
potentially be used to provide aid in prognosis and early diagnosis of conditions 
such as bovine mastitis (Conner and Eckersall, 1986) and pneumonic 
pasteurellosis (Horadogoda et a l , 1993; Horadogoda et al., 1994). Serum 
amyloid A and haptoglobin were found to be elevated in most animals which had 
a history of disease at point of slaughter (Gruys et a l, 1993) and may, therefore, 
potentially be useful in future monitoring of the health status of slaughter cattle 
and in meat inspection (Saini and Webert, 1991).
Bovine milk contains a number of plasma proteins including albumin, transferrin, 
ceruloplasmin and various immunoglobulins but prior to this investigation it was 
not known if any SAA or haptoglobin could be detected in mammary secretions. 
However, it is known that haptoglobin acts as an inflammatory marker in serum in 
E. coli mastitis which is an acute, usually self-limiting mastitis (Salonen et al, 
1996). A 52-fold increase in serum haptoglobin was measured after the first 
intramammary challenge with E. coli and the peak concentration occurred 48-120 
hours after the challenge (Salonen et a l, 1996). Thus, an APR was induced by E. 
coli mastitis and it was of interest to establish if an APR could be identified in 
milk following S. aureus infection in the present study.
SAA binds bacterial products including lipopolysaccharides (Tobias et a l, 1982), 
harmful molecules and debris produced after tissue damage (Baumann and 
Gauldie, 1994). Lipopolysaccharides are produced by Gram negative mastitis 
organisms especially the coliforms (Lipman et a l, 1995). Following intradermal 
or intravenous administration of endotoxin the concentration of SAA increased
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100-fold (Boosman et al, 1990). Hirvonen et a l (1996) studied the APR in 
heifers with experimentally induced mastitis, by measurement of serum 
haptoglobin, acid soluble glycoproteins, plasma fibrinogen and alpha-1 -proteinase 
inhibitor. They concluded that haptoglobin and acid soluble glycoproteins were 
the most effective in indicating the severity of infection and predicting the final 
outcome of the disease, whereas alpha-1 -proteinase inhibitor activity was of low 
diagnostic value in this study. The measurement of alpha-1- antitrypsin and 
bovine serum albumin in milk as an indicator of mastitis was carried out by 
Sandholm et a l (1984), who concluded that alpha-1-antitrypsin was an effective 
indicator of mastitis. Recent studies at Glasgow Veterinary School indicate that 
the SAA is a more sensitive marker for inflammation than haptoglobin (Eckersall, 
personal communication). Therefore, a major aim of this study was to identify 
and quantify SAA in mastitic milk and a monoclonal antibody raised specifically 
against bovine SAA was desirable for the development of a standard detection 
assay, as alternative antisera had proved to be unreliable, and ultimately to be 
unavailable. In order to achieve this, bovine SAA had to be accurately identified 
and purified before being used as the antigen in monoclonal antibody production. 
Identification of bovine clinical cases with elevated SAA concentrations proved to 
be difficult, as cattle which were considered to be affected by clinically- 
recognisable inflammatory conditions did not have consistently high levels of 
SAA. The previously reported correlation between elevated haptoglobin and 
SAA concentrations reported by Horodagoda et a l (1994) was not consistently 
observed in the cases studied during this project. However, bovine SAA was 
identified from a proportion of randomly selected clinical cases including those 
with infectious and inflammatory conditions, using, a commercial polyclonal rabbit 
anti-human antibody. The specificity of reaction with this antibody was confirmed 
originally by staining of a low molecular weight band of approximately 12,500 
Daltons, which was consistent with the SAA band identified in previous studies. 
Sera with high concentrations of SAA were pooled, and SAA was then purified 
by ultra-centrifugation, dialysis, lyophilisation, electrophoresis and electro-elution. 
The purification of SAA by these methods resulted in isolation of purified bovine 
SAA with a concentration of approximately 200|ig/ml. Development of this
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method during the project provided an alternative to the hydrophobic interaction 
chromatography and repeated gel filtration previously performed by Horadagoda 
et a l (1993) in the purification and quantitative measurement of bovine SAA 
Thus, the newly developed method did not require the high ionic strength 
guanidium chloride, used previously to desalt the SAA and to keep it solubilised. 
The gel filtration step had previously led to high loss of protein and was avoided 
in the current method. Hydrophobic interaction chromatography was also used as 
a purification method for human SAA by Raynes and McAdam (1988) with 
affinity chromatography used in the preparation of hamster SAA (Niewold and 
Tooten, 1991). Rossevatn et a l (1992) purified SAA by isolating the HDL 
fraction by ultracentrifugation followed by de-lipidation and gel filtration. 
Purification of proteins from polyacrylamide gels (Harlow and Lane, 1988) is a 
standard method in parasitic antigen separation (McKeand, 1992) and purification 
of proteins by electro-elution for subsequent use in antibody production has been 
successfully carried out by many authors including Kennedy et a l (1986) and 
Tomlinson et a l (1989). Antigens purified from polyacrylamide gels often induce 
good antibody responses even though some denaturation of the antigen occurs. 
Indeed, many molecules become more immunogenic following denaturation, as 
injecting denatured antigens is more likely to produce an antibody response 
against epitopes that are not found on the native antigen (Harlow and Lane, 
1988).
In this study, the production of a monoclonal antibody to bovine SAA was 
unsuccessful. No response was observed in the sera from mice immunised with 
bovine SAA and analysed by immunodot-blot. Unfortunately, it was not possible 
to attempt further immunisation required for monoclonal antibody production 
during this short project. Further attempts at antibody production should examine 
alternative strategies, including the effect of varying dose of immunising antigen, 
the effect of the isolation procedure on the native state of the protein which may 
have rendered it non-immunogenic (Zola, 1995), and the strain of mouse used for 
monoclonal antibody production, as not all strains of mouse are equally 
responsive to a particular antigen (Mouton et al, 1988). As SAA is a low 
molecular weight antigen (Rossevatn et al, 1992) which may be too small to
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induce immunity, an alternative strategy was employed to stimulate a response by 
binding SAA to a protein carrier, apoferritin (Harlow and Lane, 1988). 
However, immunisation with bovine SAA-apoferritin complex again produced no 
antibody response in the sera from mice when analysed by ELISA.
Serum amyloid A was detected initially in this study using a polyclonal rabbit anti­
human SAA antibody. Only a very small volume of this antibody was available 
and it was not possible to obtain sufficient quantities of it from any source in 
order to complete the study. An exhaustive assessment of alternative antibodies, 
both monoclonal and polyclonal, failed to identify a suitable replacement antibody. 
The lack of a suitable antibody for the detection of bovine SAA emphasises the 
need for the production of a successful monoclonal antibody which could be used 
for the accurate detection of bovine SAA in future work.
One aspect of this part of the project was to try to identify and quantify the acute 
phase proteins haptoglobin and SAA in milk following intramammary challenge 
with S. aureus. Haptoglobin levels were measured in the skimmed milk fraction 
of samples taken from two quarters in all four cows. Our results showed an 
increased haptoglobin concentration in only one quarter in one cow. The 
increased haptoglobin was detected in the LH quarter which was originally 
uninfected and subsequently challenged with strain B on day 8  post-challenge. 
The haptoglobin concentration increased from 0.22g/l on day 3 post-challenge to 
0.50g/l on day 8  post-challenge and then returned to a basal level of 0.17g/l on 
day 17 post-challenge. In the other quarter of this cow, which was originally 
uninfected and received no intramammary challenge, and in all quarters sampled 
from the other cows, haptoglobin levels remained within the normal range despite 
the presence of active infection. This suggests that haptoglobin may not be a 
useful marker of inflammation in mammary secretions following infection with S. 
aureus. This may be due to the chronicity of the original subclinical infection or 
perhaps the challenge dose failed to induce a detectable acute phase response 
when other inflammatory mediators may predominate in the gland. Another 
explanation as to why elevated haptoglobin were not detected may be the choice 
of days on which the samples were taken. An elevation in haptoglobin due to the
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acute phase response may have occurred between two of the sampling dates 
which were at least five days apart and returned to base levels by the time the next 
samples were taken.
Due to the lack of a reliable antibody for the detection of bovine SAA, SDS- 
PAGE was carried out to determine if SAA was present in milk by estimating the 
molecular weight of the suspected SAA protein and by comparing it with the 
semi-purified SAA. Only cow 703 was studied following analysis of haptoglobin 
results, as she had been the only cow to show elevated levels of haptoglobin. A 
protein of similar molecular weight to SAA was detected in the LH quarter on day 
8  post-challenge. Identification of SAA by molecular weight in milk was not 
straightforward as there are many other proteins in milk of similar molecular 
weights to SAA, whereas serum SAA can be clearly identified by SDS-PAGE as 
the majority of other serum proteins are considerably larger in size. This part of 
the work is incomplete as no antibody was available to confirm immunologically 
that this protein was indeed SAA at the point when the present project finished.
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Chapter 4
General Discussion
In this study, the experimental approach was to infuse large numbers of S. aureus 
bacteria into quarters which were originally infected with subclinical mastitis 
caused by S. aureus, and also into quarters which were uninfected. Although the 
numbers of bacteria infused during this project were much greater than in 
previously published work, the S. aureus strains were derived originally from 
cows with subclinical S. aureus mastitis and were probably less virulent than many 
S. aureus strains. In three of the four cows studied, the resulting mastitis was 
acute, with obvious swelling and reddening of the udder, but the cows did not 
show signs of being sytemically ill. The fourth cow, however, became anorexic, 
developed a marked pyrexia, and was subsequently treated with antibiotics.
Two main strains of S. aureus, strain A and strain B, were identified by REFP and 
used in the challenge studies. Quarters which were naturally infected with S. 
aureus and then challenged by the intramammary route with S. aureus, remained 
persistently infected three weeks following challenge, irrespective of the challenge 
strain. Quarters which were uninfected at the beginning of the project and were 
subsequently challenged with either strain, also remained persistently infected 
throughout the study. These results confirm the chronicity of S. aureus 
intramammary infection which is well recognised in the field and in experimental 
studies.
The results showed that in the cow infected subclinically with strain A, 
intramammary challenge with the indigenous strain of S. aureus into the infected 
quarter failed to induce an anamnestic immune response which might have
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instigated clearance of the original infection from the quarter. In the cow infected 
subclinically with strain B, intramammary challenge with the indigenous strain of 
S. aureus into the infected quarter resulted in the original strain B being replaced 
by a heterologous population of distinct strains R3, R6 and R7 in that quarter. It is 
possible that a secondary immune response to the indigenous strain B resulted in 
clearance of the original stimulating bacteria thus allowing a different strain to 
multiply and establish infection in the quarter.
This study also suggests that intramammary challenge of subclinically infected 
quarters with the non-indigenous strain did not result in permanent replacement of 
the indigenous strain with the recently infused non-indigenous strain. In the cow 
infected with strain A and challenged with strain B, strain A was not detected at 
any point following intramammary challenge. In contrast, in the cow infected with 
strain B and challenged with strain A, strain A was detected on day 3 post 
challenge, although only transiently, and by day 8  the original strain B had again 
become the predominant strain in that quarter.
REFP analysis also identified eight S. aureus strains other than the two main 
strains involved in the study. One additional strain was designated strain A* and 
was found to be very similar to strain A, with a coefficient of variation of 96% 
and 24 out of 25 fragments matching on REFP analysis. Seven other additional 
strains R1-R7 were also identified in the same way, but they showed lower 
coefficients of variation and reduced numbers of matching fragments when 
compared to strain A or strain B. It may be postulated, therefore, that while strain 
A* was likely to be a clonal variant derived from strain A, the strains R 1 - R 7  may 
be unrelated to strain A and strain B. The identification of these strains from 
individual quarters both pre- and post-challenge indicated that a cow, or even a 
quarter, may be infected simultaneously by more than one strain of S. aureus.
REFP analysis involved multiple colony analysis from each sample, which allowed 
the identification of the presence of more than one S. aureus strain in an individual 
quarter, and which would have failed to have been detected on routine single 
colony analysis. This study showed that the examination of multiple colonies per
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milk sample identified the diversity of S. aureus strains present and maximised the 
benefit of bacterial strain identification as an epidemiological tool in mastitis 
investigation. However, REFP analysis is a time consuming method, involving a 
lengthy process to obtain sufficiently purified DNA. The REP-PCR technique 
was developed during this project to facilitate more rapid identification of bovine 
S. aureus strains. REP-PCR analysis was shown to be a successful rapid technique 
for the differentiation of all but one bovine S. aureus strain isolated in this study. 
This method did not allow differentiation of strain A* from strain A. In order to 
overcome this problem, digestion of the PCR product by a number of restriction 
endonucleases was carried out. Of the endonucleases tested, only Stu 1 was 
found to produce a variation in amplification products which enabled 
discrimination of strain A* from strain A.
Future developments of this part of the work should involve further validation of 
the REP-PCR with analysis of a wider range of S. aureus isolates. In this study, 
the DNA was purified for REP-PCR using the method for REFP which is a two- 
day process but which results in large quantities of ‘purified’ DNA. Another 
development of this technique would be to improve the method for isolating 
bacterial DNA, allowing a more rapid purification method to be incorporated into 
the REP-PCR.
The experimental challenge model developed during this project may be more 
suitable for future investigations of mammary gland infections caused by S. aureus 
strains associated with subclinical mastitis, than strains derived from clinical cases 
or from commonly used laboratory strains. Now that a safe, relatively repeatable, 
method for infusion of these strains of S. aureus has been developed, it is 
necessary for further work on intramammary challenge with different strains to be 
carried out in greater numbers of cows. This is important to establish if either 
changes in, or persistence of, certain S. aureus strains are the result of the strain 
employed, or are the result of immune responsiveness of the individual cow. It 
would be a useful avenue for further study to examine the competitive behaviour 
of strains A and A* in vitro and also following intramammary challenge. It is
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possible that strain A* is more ‘fit* than strain A in terms of persistence in the 
mammary gland perhaps by virtue of reduced antigenicity.
To investigate the acute phase response as an indicator of inflammation in 
mastitis, mammary secretions from the four cows with naturally occurring 
subclinical mastitis caused by S. aureus were collected prior to, and following, 
intramammary challenge with S. aureus. Serum amyloid A was isolated and 
purified from the serum of bovine clinical cases by ultracentrifugation, gel 
electrophoresis and electro-elution. Serum amyloid A was identified by enzyme 
linked immunosorbent assay and immunoblotting using a polyclonal rabbit anti­
human SAA antibody. The purified SAA was used to immunise mice in an 
attempt to produce a monoclonal antibody against bovine SAA but this proved to 
be unsuccessful, even when the SAA was bound to a carrier protein. Increased 
levels of haptoglobin were identified in a single quarter of one cow. This quarter 
had been originally uninfected and then challenged by the intramammary route 
with strain B. In the absence of a polyclonal or monoclonal antibody to bovine 
serum amyloid A, SDS-PAGE was used to identify proteins in mammary 
secretions with a similar molecular weight to serum amyloid A. A protein of 
similar molecular weight to serum amyloid A was identified in the same quarter in 
which the increased haptoglobin levels were measured. These preliminary results 
suggest that haptoglobin is not a suitable candidate as a marker of the acute phase 
response in S. aureus mastitis as all but one of the infected quarters has normal 
levels of this acute phase protein. Further investigation of the levels of SAA in 
infected mammary secretions will require the development of suitable antibodies 
or detection systems.
One possible method which could be used in the future to produce a successful 
monoclonal antibody to detect bovine SAA could be to sequence and express 
bovine SAA. The gene encoding bovine SAA (Rossevatn et al, 1992) would be 
amplified using PCR, with the products of amplification cloned using a standard 
cloning vector. Purified plasmid DNA samples could then be sequenced. The 
amino acid sequence for bovine SAA has already been determined (Rossevatn et 
al, 1992) and once the DNA sequence has been accurately established, a gene
124
fusion system would be employed to obtain high level expression of the SAA. 
Recombinant SAA fusion proteins following purification, would be used for 
monoclonal antibody production and the development of specific immunological 
assays. Further work is required in order to assess the usefulness of SAA and 
other acute phase proteins in integrated quality control of meat and dairy 
products.
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Glossary
1° primary
2° secondary
A* variant strain
AA amyloid A
AEC amino ethyl carbazole
APP acute phase protein (s)
APR acute phase response
B cells B lymphocytes
BCA bicinchoninic acid
BHI brain heart infusion
BSA bovine serum albumin
BMSCC bulk milk somatic cell count (s)
°C centigrade (celsius)
cm centimetre
CRP C-reactive protein
Da Dalton
dATP deoxyadenosinetriphosphate
dCTP deoxycytosinetriphosphate
dGTP deoxyguanidinetriphosphate
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
dTTP deoxythyminetriphosphate
EDTA ethylenediaminetetra-acetate
ELISA enzyme linked immunosorbent assay
g gram
FCS fetal calf serum
HRP horseradish peroxidase
HDL high density lipoprotein
IL-1 Interleukin-1
IL-6 Interleukin-6
1 2 6
ICSCC individual cow somatic cell count (s)
IgA immunoglobulin A
IgGi immunoglobulin G type 1
IgG2 immunoglobulin G type 2
IgM immunoglobulin M
IQSCC individual quarter somatic cell count (s)
Kcl potassium chloride
kDa kilo Dalton
X lambda
1 litre
LDL low density lipoproteins
LF left fore
LH left hind
mg milligrams
MgCl magnesium chloride
ml millilitre
MLEE multilocus enzyme electrophoresis
mm millimetre
mM millimolar
NaCl sodium chloride
NAGase N-acetyl-P-D-glucosaminidase
NaH2P 0 4 sodium dihydrogen orthophosphate
Na2P 0 4 disodium hydrogen monophosphate
PBS phosphate buffered saline
PBS-T phosphate buffered saline-Tween 20
PCR polymerase chain reaction
PHA phytohaemmagglutinin
PMNL polymorphonuclear leucocyte (s)
REF restriction endonuclease fingerprinting
REFP restriction enzyme fragmentation pattern
REP-PCR repetitive extragenic palindromic polymerase chain
reaction
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RF right fore
RH right hind
RNA ribonucleic acid
SAA serum amyloid A
SDS sodium dodecyl sulphate
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel
electrophoresis
SMCC Four- (N maleimidomethyl) cyclohexane carboxylic
acid N-hydroxy succinimde ester 
TBC total bacterial count (s)
TBE Tris base, boric acid disodium EDTA
TBS-T Tris buffered saline-Tween 20
T cells T lymphocytes
TE Tris base disodium EDTA
TEio lOmM Tris base, lOmM disodium EDTA
TEMED N’, N ’, N’, N’,-tetramethylethylenediamine
TES Tris ethylene diamine tetra acetic acid in sodium
chloride buffer
TMN 3, 3’, 5, 5’-tetramethylbenzidine
TNFa tumour necrosis factor-alpha
Tris-HCL Tris base buffered in hydrochloric acid
TSST-1 toxic shock syndrome toxin-1
p micro
pg microgram
pi microlitre
pmol micromole
v/v volume per volume
w/v weight per volume
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